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Nanoparticles are promising platforms for biomedical applications ranging from di-
agnostic tools to therapeutic delivery agents. During the course of these applica-
tions, nanoparticles are exposed to a complex mixture of extracellular serum proteins
that nonspecifically adsorb onto the surface. The resulting protein layer, or protein
“corona,” creates an interface between nanoparticles and the biological environment.
Protecting the nanoparticle surface can reduce protein adsorption, but complete in-
hibition remains a challenge. As a result, the corona, rather than the nanoparticle
itself, mediates the cellular response to the nanoparticle. The following dissertation
describes the fundamental characterization of the cellular binding of charged nanopar-
ticles, interactions of protein-nanoparticle complexes with cellular receptors, and the
structural and thermodynamic properties of adsorbed corona proteins.
Cationic, amine-modified and anionic, carboxylate-modified polystyrene nanopar-
ticles were studied as a model system. We observed that initial nanoparticle surface
charge dictates cellular binding in the presence of extracellular serum proteins. The
charge-dependent differences are attributed to protein-nanoparticle complexes bind-
ing to distinct cellular receptors. Similar trends were observed for a collection of
nanoparticles differing in size, composition, and surface modification, demonstrating
that nanoparticle surface charge determines cellular binding trends for a broad range
of nanoparticles. Characterization of the protein-nanoparticle complex was extended
to include structural and thermodynamic studies of adsorbed proteins. Molecular
properties of adsorbed proteins were correlated with the cellular receptors used for





1.1 Nanoparticles for Biomedical Applications
Nanoparticles (NPs) have generated broad scientific interest as platforms for biomed-
ical applications.1–9 Sophisticated synthetic control of the aspect ratio, surface func-
tionalization, and size-dependent optical properties has led to a diverse collection of
nanomaterials well-suited for the biological environment. The large surface area-to-
volume ratio enables targeting ligands, imaging agents, and therapeutics to coexist
in the same particle.10 Intrinsic length scales allow NPs to directly probe individual
cellular components and, if small enough, be cleared by the renal system.11 Recent ap-
plications include gold NPs for drug delivery and cancer therapy,9,12–14 quantum dots
(QDs) as cellular sensors and imaging agents,5–7 and liposomal NPs for vaccinations
and delivery systems.15–17 While the field of nanomedicine is promising, nonspecific
NP interactions with biomolecules, toxicity, and unpredictable biodistribution still
limit the clinical use of most NP-based platforms.15,18 In order to advance the use of
NPs in biology and medicine, fundamental characterization of NP interactions with
biomolecules and cells is essential.
NPs used in biological systems are exposed to a complex mixture of extracellular
proteins. The high surface energy of the NP leads to rapid adsorption of a protein
layer, or “corona,” on the NP surface.19–21 The formation of a protein corona has
been observed on a wide range of materials including gold,22–24 silver,25 and polymeric
NPs.26–28 The corona composition is dynamic and highly dependent upon NP material
and surface modification. Functionalizing the NP surface with polyethylene glycol
(PEG) can reduce but not completely eliminate protein adsorption. The composition
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of the corona, energetics of formation, and dynamic identity all influence the response
of single cells to the protein-NP complex. A complete understanding of the interface
between NPs and the cellular environment requires characterization of how adsorbed
proteins mediate NP interactions with cells, as well as the ways in which the NP
surface induces molecular level changes to the adsorbed protein.
1.2 Protein Corona
For most biomedical applications, NPs are injected directly into the blood stream
where they encounter red and white blood cells, clotting factors, inorganic salts, and
extracellular proteins.29,30 Plasma is the soluble protein component of whole blood
after the red and white blood cells are removed.30 Further purification of plasma
separates the clotting factors, such as fibrinogen, from serum. Serum is a diverse
mixture containing hundreds of distinct proteins.31,32 Of particular interest has been
the observation that NPs exposed to biological fluids are readily coated with a layer of
proteins adsorbed to the surface.19–21,33,34 The presence of a protein layer, or protein
corona, has been observed after exposure to both plasma35,36 and serum.24,28,37,38
The protein corona defines the interface between the NP and the biological sur-
roundings and, as a result, controls NP-cell interactions.37,39–45 Studying the forma-
tion of the corona is complicated both by the number of unique plasma proteins
and the dynamic nature of the biological environment. In the presence of cells, the
dynamics become even more pronounced as a continuous, localized flux of ions and
biomolecules exists to maintain necessary cellular homeostasis, altering the local en-
vironment around both the NP and protein.41 Protein corona composition is highly
dependent upon NP properties such as size23,33 and surface modification,27,46 ener-
getics of formation,47 and time.34,38
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1.2.1 Composition
The presence of a protein corona has been observed on a diverse range of NP surfaces
including polymeric NPs,26–28,37 silica NPs,42 QDs,24,48 iron oxide NPs,49 silver nan-
oclusters,50 silver NPs,25 gold nanorods,51,52 and gold NPs.22–24,53 The corona is dom-
inated by albumin,19,24,28,34–36,38 the most abundant protein in serum (55%).31,32,54
Lower abundance serum proteins such as apolipoproteins, fibrinogen, and immunoglob-
ulins are also commonly observed,26,35,36 and can be present in high abundance on
NP surfaces despite their relatively low concentrations in plasma. This highlights the
fact that the NP itself can greatly influence the composition of the corona. Recently,
an ‘adorbsome’ was identified consisting of 125 plasma proteins that have been de-
tected on NP surfaces.55 Although many different proteins can bind to NP surfaces,
a general trend has emerged where a few (2-6) proteins compose the majority of the
corona.55 While the focus of this dissertation is on protein interactions with NPs, it
is important to note that other plasma components such as lipids and complement
factors also bind and contribute to the overall cellular pathway of the NP.44
Several NP properties influence the composition of corona proteins including ma-
terial,26,36,46 charge,56 surface properties,25,27,33,46,47,49 and size.23,26,33,57 For example,
Monopoli et al. have observed that for sulfonated polystyrene NPs and silica NPs of
similar size, serum albumin and fibrinogen are the main components of the corona.36
However, both apolipoproteins and complement proteins are more abundant on the
hydrophilic, polystyrene NP surfaces, and the composition was dependent upon the
plasma concentration. NP size also influences the identity of corona proteins. For
gold NPs of 5, 15, and 80 nm, protein composition and binding was investigated as a
function of diameter.23 While albumin, hemoglobin, fibrinogen, and apolipoprotein E
were observed on NPs of all diameters, proteins such as myosin and apolipoproteins
A2 and A4, were only detected on the 5 nm gold NPs. The 5 nm NPs also bound the
most proteins per surface area, attributed to a greater radius of curvature. Generally,
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differences in adsorption as a result of size are attributed to NP curvature, especially
in cases where the NP and protein are of similar size.
The charge on the NP also influences protein binding, especially for proteins with
several charged residues. Gessner et al. have demonstrated that positively charged
polystyrene NPs preferentially bind proteins with an isoelectric point (pI) < 5.5, while
negatively charged NPs bind proteins with a pI > 5.5.27 The effect of pH on protein
adsorption reinforces the need to characterize NPs for biological applications in an
environment that best imitates the buffered, slightly basic, physiological environment.
1.2.2 Energetics of Formation
The primary forces that control protein binding to NP surfaces include hydrophobic
interactions, electrostatics, and Van der Waals forces.21,41,47,58,59 Hydrogen-bonding
and π-π stacking can also contribute to the overall protein binding force.47,58 The rel-
ative contributions from each force vary in the literature based on the NP material,
functionalization, and protein characteristics.47,59,60 Yoon et al. observed that ad-
sorption of proteins to microspheres is dominated by hydrophobic interactions when
the surface charge is low, but determined by electrostatics when the particle sur-
face is completely modified with charged functional groups.47 Kondo and Higashitani
reported that adsorption isotherms of several proteins to hydrophilic, but not hy-
drophobic particles were dependent upon pH, concluding that both hydrophobic and
electrostatic interactions control protein adsorption to particle surfaces.60
Hydrophobic interactions, driven by entropy, play a significant role in protein
interactions with surfaces. Protein adsorption minimizes exposure of hydrophobic
residues to polar solvent molecules and is usually accompanied by a loss of bound
water molecules. Adsorption increases as the hydrophobicity of either the NP surface
or the protein increases.59,61 While the exact contribution of hydrophobic forces is
difficult to deduce in a complex mixture of proteins, the important consequence of the
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hydrophobic interaction is the potential for protein unfolding. As unfolded proteins
generally contain more exposed hydrophobic residues (and potentially higher valency),
unfolded proteins will have a higher affinity for hydrophobic surfaces. Structural
changes to corona proteins after interaction with NP surfaces will be covered in Section
1.3.
Electrostatic interactions often contribute to the formation of the protein corona
as both NPs and proteins contain some degree of surface charge. Electrostatic forces
are generally long-range interactions which scale inversely with distance squared
(Coulomb’s law).62 However, the high ionic strength of biological fluids (150 mM)
screens the electrostatic force beyond ∼10 nm from the NP surface.41,58,62 While most
NPs become net negatively charged in biological media,28,41,51 attractive forces are
still present due to charged surface ligands on the NP surface. In addition to the NP,
most proteins have regions of both positive and negative surface charge. For exam-
ple, serum albumin, the most abundant serum protein,31 is net negatively charged at
physiological pH (pI ∼4.7) but contains 60 positively charged lysine groups.63,64 Elec-
trostatic interactions are highly dependent upon the pH of the surrounding medium
as well as the accessibility of positively and negatively charged functional groups on
both the NP and protein surface.
While Van der Waals forces are generally weak and decay rapidly as a function of
distance, they contribute to protein-NP interactions at short range. The continuous
fluctuation of electrons in both proteins and on NP surfaces creates small, localized
dipole moments, both permanent and induced. The dipole moments generate attrac-
tive (or repulsive) regions of the NP surface where proteins and other macromolecules
can bind. While the dipole moments for individual atoms are small, the net dipole
moment across a large molecule, such as a protein or protein domain, is significant.
Importantly, the localization of dipole moments means that the total interaction is
maximized with a larger contact area, so NP size and the folded state of the protein
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both largely influence the total Van der Waals forces.
All of these forces, among others, work in an orchestrated fashion to balance both
enthalpic losses and entropic gains. While protein adsorption to surfaces is not a
new area of research,65 a full understanding of protein binding to NPs remains a
challenge. The thermodynamics and energtics of binding eventually determine the
protein composition, dynamics of protein adsorption over time, and molecular level
changes in protein structure, all of which ultimately influence NP interactions with
cells.
1.2.3 Dynamics
While the identity of the protein corona is dependent upon NP properties, ultimately,
the corona composition is dynamic. Protein adsorption to surfaces is a competitive
process, a phenomenon referred to as the Vroman effect.66,67 Higher mobility proteins
initially bind, forming a weakly bound “soft” corona composed primarily of albu-
min.26,39 The soft corona is replaced over time with a “hard” corona composed of
proteins, such as apolipoproteins, with a lower mobility but higher affinity for the
surface.26,34 Often, both an irreversible hard corona and a weakly bound soft corona
in equilibrium with free proteins in solution exist simultaneously.68 Experimentally,
protein adsorption is fit biexponentially to calculate separate rate constants (k on and
k off ) for proteins forming the soft versus hard corona.
34,55 Corona formation dynamics
have also been simulated numerically using population balance equations and results
were consistent with experimental observations.69 An initial metastable corona of al-
bumin was observed and later replaced by a stable layer of high-density lipoprotein,
which was used as a model particle.
The dynamic evolution of the protein corona has been observed on NPs of var-
ied composition26,34,44 and size,38,44 in a range of plasma concentrations,38 and in
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both plasma and cytosolic fluid.70 Factors such as protein association strength, dif-
fusion constant, conformational changes, and local environment all influence the ki-
netics. Coarse-grained molecular dynamics simulations have modeled the contribu-
tions to the Vroman effect, concluding that protein size, affinity, diffusion constant,
and conformational changes contribute to the competitive adsorption that precedes
equilibrium.71 The dynamic process by which proteins adsorb and desorb has sig-
nificant cellular consequences. Competitive protein adsorption leads to NPs with a
varied corona composition over time. Differences in exposed proteins and protein
epitopes, changes in protein structure, and varying degrees of protein coverage all
affect receptor-mediated binding, internalization pathways, and the immune response
to the protein-NP complex.39,44
1.2.4 Inhibition
NPs for medicinal applications must interact with the biological environment pre-
dictably. Nonspecific protein adsorption and opsonization quickly direct foreign ma-
terials to the mononuclear phagocyte system (MPS). Rapid clearance reduces efficacy
of nanomaterials and triggers undesirable immune responses. While many efforts have
been made to prevent the formation of the corona, complete inhibition remains a
challenge.55,72–74 Protecting the NP surface with PEG is currently the most common
method for reducing protein adsorption.55,73,74 PEG can be incorporated during NP
synthesis, usually with a block copolymer, or post-synthetically by chemically attach-
ing the polymer chain to the surface.75–77 NPs coated with PEG have an increased
blood circulation time,73,74,78 avoid uptake by the MPS,79 and prevent activation of
the complement system.73 In general, an increased cirulation time leads to greater
efficacy of nanomedicines, as greater retention affords the NP prolonged time to reach
the intended biological target.
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The PEG chain length and polymer configuration both significantly alter the de-
gree of protein adsorption. Two polymer configurations, brush and mushroom, are
possible for PEG terminally grafted onto a surface.75–77 The brush configuration con-
sists of long chain polymers densely packed on the surface, where the distance between
the chains is less than the Flory radius. The Flory radius is the effective hydrody-
namic radius accounting for excluded volume around the polymer.75 The mushroom
configuration arises from a less dense polymer layer where the distance between chains
is larger than the Flory radius. Polymer chains are collapsed into a mushroom for-
mation on the surface as a result of repulsion between neighboring chains. Maximum
prevention of protein adsorption is achieved with a dense layer of PEG in the brush
configuration.73,74,76,77 The dense layer of the polymer reduces protein adsorption by
increasing steric hindrance and introducing a high entropy cost of protein binding.76,77
The PEG length and molecular weight necessary to prevent adsorption is dependent
upon the NP material and size as well as the size and molecular weight of the pro-
tein. For example, polylactic acid NPs were coated with PEG chains with molecular
weight values ranging between 2,000 to 20,000 g·mol−1.74 The optimal PEG coat-
ing for maximum protein reduction was 5% (w/v) PEG with a molecular weight of
5,000 g·mol−1 in a brush configuration. Increase in either molecular weight or weight
percent of PEG did not reduce protein adsorption further. While passivation with
PEG is the most common method, drawbacks include rapid clearance of NPs over
long time periods, limited interactions with cellular receptors, and the prevention of
targeted uptake.55,74,80 Alternatives to PEG, including polysaccharides81,82 and zit-
terionic copolymers,83,84 have shown recent promise in reducing protein adsorption.
Preventing protein adsorption remains an active area of research for all exogenous
materials introduced into the body. While the protein corona can be reduced, some
degree of protein adsorption will persist. The effectiveness of antifouling must be
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systematically deduced for each NP, characterizing both the reduction in protein ad-
sorption as well as the effects on biodistribution and immune response.
1.2.5 Biological Consequences of the Corona
Arguably, the most significant consequence of the protein corona is the ability for
the adsorbed proteins to control NP interactions with the biological environment.
The corona can protect against NP-induced cellular toxicity and particle aggrega-
tion.42,85 Proteins remain bound as the NP crosses biological barriers,40 and as a
result, influence cellular binding and internalization of the NP.28,43–45 The adsorbed
proteins can also mask targeting ligands on the NP surface, directing the NP away
from the intended cellular target.86 Both nonspecific physical interactions and specific
recognition of the protein-NP complex are affected by corona formation, ultimately
determining NP-cell interactions and the overall immune response.
Direct, nonspecific interaction of the high energy surface of NPs with cellular
components can be damaging and lead to a cascade of undesirable consequences.
Lesniak et al. have demonstrated that NPs exposed to A549 lung epithelial cells in
the absence of serum proteins adhere directly to the cell membrane causing cellular
damage, but the presence of serum proteins mitigated cytotoxity.42 Similar results
were observed for graphene oxide.87 In addition to protecting cells from the high
surface energy, serum proteins increase the stability of NPs in solutions with a high
electrolyte content. The adsorption of serum proteins shields neighboring NPs and
prevents aggregation via electrostatic and steric repulsion.85 Increased colloidal sta-
bility in the presence of serum proteins has been observed for gold nanorods,51 gold
NPs,88 and silver NPs.89
While protein adsorption protects NPs from nonspecific interactions, the corona
also enables specific recognition of the NP by biological and cellular components.39,90
Though there will always exist some degree of exchange between proteins on the NP
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surface and free proteins in solution, our group previously observed that bovine serum
albumin (BSA) stays bound to the surface of polystyrene NPs during both cellular
binding and internalization.37,40 These experiments have two important implications.
The first is that adsorbed proteins determine the cellular transport of NPs as they are
not displaced during NP interactions with cells. The second is that proteins remain
bound as the NP crosses a biological membrane and into an environment with a
different pH and protein concentration. These experiments used isolated BSA as a
model serum protein, and it is still relatively unknown how the composition of the
corona changes as NPs cross biological barriers, i.e. lipid membranes or organelles.
Previous work characterizing the corona after transfer from plasma to cytosolic fluid
suggests that, while the corona composition differs after transfer, the final corona
contains proteins from both solutions. The potential for NPs to retain a ‘memory’ of
proteins encountered throughout biological transport has direct implications for NP
accumulation and clearance mechanisms. The challenge lies in controlling protein
adsorption throughout the total circulation time until clearance, and will be unique
for every NP and each local environment the NP encounters.
Since proteins remain bound to the NP during cellular binding, the corona, rather
than the NP, determines the cellular receptors used by protein-NP complexes. Chap-
ters 3 and 4 demonstrate that the presence or absence of serum proteins leads to
different cellular binding trends for cationic versus anionic NPs. We have observed
that protein-NP complexes formed with cationic NPs bind to scavenger receptors, a
class of nonspecific receptors used to bind degradation products and a diverse range
of biomacromolecules.91–95 In comparison, protein-NP complexes formed from anionic
NPs bind to native protein receptors, specifically the albumin protein receptor. We
observed these trends for cationic and anionic polystyrene NPs,28 and anionic QDs,
colloidal gold nanospheres, and low-density lipoprotein (LDL).24 The importance of
the corona on the cellular binding and internalization of NPs has also been observed
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in the literature for silica,44,96 polymeric,43–45,96–98 silver,50 and gold NPs.99
Adsorbed proteins provide NPs with specific binding sites on the cell surface as
many serum proteins have dedicated cellular receptors. However, the binding speci-
ficity of corona proteins has the potential to mask targeting ligands on the NP surface.
A reduction in targeting capability has been observed for transferrin-conjugated sil-
ica NPs.86 The transferrin on the NP surface can bind the native transferrin receptor
in vitro, but the targeting capabilities are masked by the adsorption of serum pro-
teins. A similar loss in targeting was observed for a model reaction between NPs
functionalized with a cycloalkyne, bicyclonyne group and azide groups on a silicon
substrate. The bicyclonyne groups conjugate to the terminal end of the azide through
a copper-free click reaction in the absence of serum, but the targeting efficiency is
reduced by 94% in the presence of 10% serum.100 While loss of targeted NP binding
in vivo remains unknown, these in vitro experiments demonstrate the potential for
unpredictable NP-cell interactions after corona formation.
Many NP properties affect protein corona formation and subsequent cellular in-
teractions of protein-NP complexes. However, both the composition and dynamics of
the corona, along with disruption of protein structure and function upon adsorption
to the NP ultimately determine the overall biological impact. Molecular level changes
to protein structure and function arguably have the greatest potential for causing un-
wanted toxicity and immunological responses to the NP. The following section will
discuss the effect of NP surfaces on protein structure and function.
1.3 Molecular Properties of Corona Proteins
Most of the research to date on the protein corona has focused on the composition as
a function of NP material, size, and time. However, equally important are the struc-
tural changes to the protein upon adsorption. Conformational changes, exposure of
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epitopes, and loss in protein function can all trigger cellular and immunological re-
sponses.44,45,101 This section will focus on NP induced structural changes to adsorbed
proteins and the cellular and immunological consequences of these interactions.
Protein adsorption to solid surfaces is known to alter structure and lead to par-
tial denaturation.61,65,102 As described in Section 1.2.2, there are many forces which
contribute to protein-surface interactions. Release of free energy accompanying pro-
tein adsorption is a likely trigger of protein conformational changes.41 Flexibility of
protein structure, exposed hydrophobic or charged residues, and solvent properties,
along with NP properties such as curvature, material, and surface modification all
contribute to the final protein structure. The difference in studying protein adsorp-
tion to NPs versus flat surfaces is the high radius of curvature. Interactions of proteins
with large NPs appear relatively flat to the protein. As the NP diameter decreases,
the protein will experience the curved surface. Mandal and Kraatz observed that
a helical peptide retains its secondary structure on flat surfaces and large gold NPs
(20 nm diameter), but the relative number of α-helices is reduced by nearly 80% on
smaller NPs (5 nm).103 However, even on large NP surfaces, protein structure can
be lost. We observe in Chapter 5 that serum albumin loses secondary structure on
the surface of 58 nm cationic NPs, but the structure is retained on 60 nm anionic
NPs. As many proteins can bind to a single NP upon exposure to serum, determining
the effect of protein structural changes on the physiological response to the NP is a
complex challenge.
Adsorption of proteins to many types of NPs has been observed to disrupt protein
structure.41,104–108 For albumin, the most abundant serum protein, disruption of sec-
ondary structure has been observed following adsorption to silver NPs,25,46 zinc oxide
NPs,109 gold NPs,52,110 and gold nanorods.52 Structural changes have also been ob-
served for lower abundance plasma proteins including fibrinogen,22,101,111 lysozyme,112
cytochrome c,113,114 and chymotrypsin.112 For lysozyme and chymotrypsin, the loss
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in secondary structure was accompanied by a loss in enzymatic activity.112 Using a
model protein system, the Streptococcal protein GB1 binding domain, on latex NPs,
Pan et al. observed that adsorption, accompanied by a reversible structural change,
occurs via a two-step process.108 The initial interaction of the protein with the NP
is characterized by rates of adsorption and desorption, or k on and k off , respectively.
This is followed by a conformational change with a different rate affiliated with protein
unfolding, ku, and folding, k f . The dynamic nature of protein unfolding introduces
another layer of complexity to the formation of the corona. In addition to compet-
itive adsorption between different proteins, the binding of each protein is dynamic
over time depending on the kinetics and reversibility of adsorption.
While the binding of GB1 to latex NPs undergoes a reversible conformational
change, the reversibility will be protein dependent. Mahmoudi et al. observed that
binding of the transferrin protein to superparamagnetic iron oxide NPs led to irre-
versible changes in transferrin conformation.115 Characterization of protein structure
for proteins bound to a NP and after desorption from the NP surface is critical for
determining biological interactions. The presence of denatured proteins either bound
to a NP surface or free in solution has cellular consequences. In Chapter 5, we demon-
strate that a loss in secondary structure for BSA bound to polystyrene NPs directs the
protein-NP complex away from the native albumin receptors and instead to scavenger
receptors on the cell surface. These results are consistent with previous research that
demonstrates chemically or structurally modified albumin on the surface of gold NPs
bind to a class of scavenger receptors specific to modified albumins.91–93
Misfolded proteins and aggregates in solution lead to an enhanced immune re-
sponse and are linked to a number of disease states.116,117 Polymeric NPs, cerium
oxide NPs, QDs, and carbon nanotubes were all observed to induce the nucleation
and fibrillation of human β2-microglobulin.118 However, not all proteins are disrupted
by adsorption onto NPs. A comparison of chymotrypsin and cytochrome c adsorbed
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onto 7 nm gold NPs showed that while the structure of chymotrypsin was disrupted,
cytochrome c retained its secondary structure.119 Mahmoudi et al. demonstrated that
silica NPs, polystyrene NPs, and carbon nanotubes coated with a protein corona all
slow the formation of amyloid-β fibrillation, with applications for protein misfolding
diseases.120
Both uncoated NP surfaces and protein structural changes trigger immune re-
sponses. Yan et al. observed that changes in BSA structure on the surface of poly-
meric NPs accompanied an increase in NP uptake by human monocytic cells compared
to bare NPs.45 In comparison, similar uptake was observed in macrophage cells for
NPs with and without a corona. While the differences in uptake in monocytes was
attributed to protein structure, it is difficult to separate the effect of the presence of
a corona from the effect of a change in protein structure on cellular uptake. Deng et
al. reported that unfolding of fibrinogen on gold NPs activates the Mac-1 receptor
promoting the NF-κB pathway.101 This led to a triggered immune response and the
subsequent release of cytokines in THP-1 cells. These studies demonstrate that both
the NP and the protein adsorbed to the NP can activate the immune system. A holis-
tic examination of the role of the pristine NP surface, free proteins, and protein-NP
complexes is required for a complete physiological understanding.
As disruption of protein structure induces protein aggregation, accompanies a
loss in function, and exposes new peptide sequences, or epitopes,106,121 fundamental
studies of protein structure on NP surfaces will need to be extended in vivo to un-
derstand the full biological effect of NP-induced conformational changes. For most
nanomedicines, the mechanism of how protein structure on a NP surface alters NP




The use of NPs in biology and medicine requires a fundamental characterization of
the interactions between NPs and proteins in a physiologically relevant environment,
as well as precise control over NP interactions with the surrounding biological milieu.
This dissertation focuses on the former with the ultimate goal of understanding the
molecular characteristics of the protein-NP complex and the cellular consequences
of formation. Protein-NP interactions in the cellular environment are complex and
dynamic as the protein controls the NP interactions with cells, yet the NP surface
alters the structure and molecular properties of the adsorbed protein. Our initial
observations that the presence of serum proteins enhanced the cellular binding of
cationic, polystyrene NPs led to an investigation of the role of serum proteins in
charged NP interactions with cells. Interestingly, we observed the opposite trend for
anionic polystyrene NPs as the presence of serum proteins inhibited cellular binding.
In Chapter 3, we demonstrate that initial NP surface charge dictates the cellular
binding of NPs when proteins are present. We determined that the differences are
due to protein-NP complexes binding to distinct cellular receptors. Complexes formed
with cationic NPs bind to scavenger receptors, whereas complexes formed with anionic
NPs bind to native protein receptors. We determined that these trends are not
dependent upon NP diameter or cell type. Chapter 4 demonstrates that the trends
we observed for polystyrene NP binding are consistent for anionic QDs, colloidal gold
nanospheres, and LDL. These biomedically relevant NPs differ in size, composition,
and surface modification, suggesting that initial NP surface charge is a dominating
factor in the cellular binding of NPs.
Chapter 5 extends the cellular binding results to include structural and ther-
modynamic studies of adsorbed proteins. We used NP surface charge to modulate
protein secondary structure using BSA as a model protein. We observe that protein
secondary structure is retained on anionic NPs and disrupted on cationic NPs. By
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correlating the secondary structure of proteins adsorbed to a NP surface with the
cellular receptors used to bind the protein-NP complex, we determined a molecular
level relationship between adsorbed proteins, NPs, and cellular receptors. The loss
of secondary structure on cationic NPs redirects the protein-NP complex away from
native protein receptors and instead to scavenger receptors which commonly bind
modified proteins. In comparison, the native protein structure on anionic NPs allows
these complexes to be recognized by the native albumin receptor. Future work will
extend the structural and thermodynamic studies to other NP and protein systems,
probe the relationship between structure and cellular internalization, and direct NP
binding to specific cellular receptors using our understanding of the role of both NP
surface charge and protein structure.
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[49] Jedlovszky-Hajdú, A., Bombelli, F. B., Monopoli, M. P., Tombácz, E., and
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Experiments were performed in water at room temperature unless otherwise speci-
fied. Aqueous solutions were prepared with nanopure water (18 MΩ). Concentra-
tions reported are the final concentration in solution. Experiments were repeated,
at minimum, with triplicate samples prepared independently. Cell experiments were
performed with cells from multiple passage numbers unless a uniform passage num-
ber was required. Concentrations of biological molecules are reported in mg·mL−1.
Chemicals were used without further purification unless otherwise noted.
2.1 Nanoparticle Characterization
The diameter provided by the manufacturer is used to denote the NPs throughout the
text. The following fluorescent polystyrene nanoparticles (NPs) were used in exper-
iments: 87 nm amine-modified (Invitrogen, C29029), 200 nm amine-modified (Invit-
rogen, F8764), 40 nm carboxylate-modified (Invitrogen, F8795), 93 nm carboxylate-
modified (Bangs Laboratories, FC02F), and 200 nm carboxylate-modified (Invitrogen,
F8811). The reported maximum excitation and emission wavelengths are 505 and 515
nm, respectively, and were verified with fluorescence spectroscopy in our laboratory
prior to experiments. The exception was the 87 nm NPs which have reported excita-
tion and emission maxima at 490 and 515 nm, respectively. The maximum excitation
was measured to be 480 nm with maximum emission peaks at 490 and 525 nm. Dark,
non-fluorescent 60 nm carboxylate-modified (Bangs Laboratories, PC02N) and 58 nm
amine-modified (Bangs Laboratories, PA02N) polystyrene NPs were used in exper-
iments where the fluorescence interfered with the measurement. NP solutions were
sonicated for 10-20 minutes prior to use.
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Carboxylate-modified CdSe/ZnS quantum dots (QDs, Invitrogen, Q21341MP,
emission maximum: 525 nm) were used after sonication for 10 minutes. Citrate-
modified gold NPs (Sigma-Aldrich, 753629), with a measured absorbance maximum
at 524 nm, were concentrated via centrifugation (10,000g, 10 minutes, 4 ◦C) from an
initial concentration of 0.3 nM to a final concentration between 10 and 20 nM. The
gold NPs were sonicated for 20 minutes prior to spectroscopy and cellular binding
experiments. The concentration of gold NPs was calculated using a molar extinction
coefficient (ε) of 3.36 x 109 M−1·cm−1. Low-density lipoprotein (LDL, Biomedical
Technologies, BT-903, 5 mg·mL−1 stock solution) was fluorescently labeled with 1,1’-
dioctadecyl-3,3,3’,3’-tetramethylindodicarbocyanine perchlorate (DiD, Invitrogen, D-
307; excitation maximum: 644 nm, emission maximum: 664 nm) as previously re-
ported.1 Briefly, DiD (25 mM in DMSO) was added to LDL (stock) at a ratio of
200:4 (v/v) LDL to DiD under sterile conditions. The LDL was minimally exposed
to the air to avoid oxidation. The LDL-DiD solution was mixed by gently pipetting
the solution every 10 minutes for 1 hour at room temperature. The DiD-labeled LDL
was separated from free DiD with a NAP5 size exclusion column (GE Healthcare,
17-0853) pre-equilibrated with phosphate buffered saline without calcium and mag-
nesium (PBS, Invitrogen, 14190250). A single fraction was collected from the column
and filtered with a 0.22 µm syringe filter (Fisher Scientific, 09-720-3) immediately
prior to use. The final concentration of LDL was approximated by accounting for di-
lution of the LDL stock after both addition of DiD and filtration through the NAP5
column. A final volume of between 450 and 500 µL of labeled LDL was collected, and
a 90% yield from the column was assumed using the manufacturer’s specification.
2.1.1 Protein-Nanoparticle Complexes
2.1.1.1 Washed NPs
NPs were incubated in minimum essential medium (MEM, Invitrogen, 61100061)
supplemented with 10% (v/v) fetal bovine serum (FBS, Invitrogen, 10437028) or
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10 mg·mL−1 bovine serum albumin (BSA, Fisher, BP1600) at 4 ◦C for 10 minutes.
The gold NPs were incubated at 4 ◦C for 30 minutes to match the conditions used
for cellular binding experiments. Most NPs could not be pelleted in MEM alone.
Incubation was followed by wash steps consisting of centrifugation, removal of the
supernatant, and resuspension in water. The NP concentration and number of wash
steps were optimized based on the solubility and stability of each NP (Table 1).










200 nm NH2 PS 15 nM 16,000 10 6
200 nm COOH PS 13 nM 16,000 10 6
87 nm NH2 PS 173 pM 16,000 10 4
58 nm NH2 PS 0.4 nM 16,000 10 4
60 nm COOH PS 14 nM 16,000 10 4
30 nm H3C6H5O7 gold 1 nM 10,000 10 5
2.1.1.2 Protein-Gold NP Complexes
Characterization of protein-gold NP complexes was measured using absorption spec-
troscopy. FBS (0.075 - 300 µM) was titrated into an aqueous solution of gold NPs
(0.17 nM), keeping the total volume constant between samples. The λ at the maxi-
mum absorbance of gold NPs in the presence of protein was determined from absorp-
tion spectra measured on a SpectraMax plate reader (Molecular Devices, M2e) and
averaged for triplicate measurements. Changes in λ (∆λ) relative to gold NPs in the
absence of protein (524 nm) were used with the Langmuir adsorption isotherm model
(Equation 1) to quantify surface coverage. The ∆λmax is the maximum wavelength
shift corresponding to maximum protein adsorption, K is the equilibrium association
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constant (M−1), and [protein] is the molar FBS concentration. The Langmuir equa-
tion was fit linearly using a Lineweaver-Burk plot (Equation 2). The inverse of the

















2.1.2 Dynamic Light Scattering and Zeta Potential Measurements
The hydrodynamic diameter and zeta potential of the NPs was measured with a
Malvern Zetasizer (Malvern Instruments, Nano-ZS). NPs were measured in water
at the following concentrations: 87 nm amine-modified (173 pM), 200 nm amine-
modified (15 pM), 40 nm carboxylate-modified (3.3 nM), 200 nm carboxylate-modified
(13 pM), 93 nm carboxylate-modified (37 pM), 60 nm carboxylate-modified (1.4 nM),
and 58 nm amine-modified (1.4 nM) polystyrene NPs, QDs (80 nM), and gold NPs
(0.75 pM). The hydrodynamic diameter of the QDs could not be measured reliably
with dynamic light scattering due to strong absorption and fluorescence of the scat-
tering laser. From a previous literature report, the diameter in water is ∼10 nm.2
LDL was incubated in MEM and diluted in water to a working concentration of 1
µg·mL−1; a buffered solution was required to obtain a reliable measurement. NP
concentrations were optimized based on the stock NP solution. For washed NPs,
the protein-NP pellet collected after the final wash step was resuspended in water
for dynamic light scattering measurements. The 60 nm carboxylate-modified and 58
nm amine-modified NPs were also measured in colorless MEM (Invitrogen, 51200038)
and MEM supplemented with either 10% (v/v) FBS or 10 mg·mL−1 BSA. Solutions
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prepared with MEM were diluted by 10% (v/v) for zeta potential measurements to
reduce the conductivity. For the 58 nm amine-modified NPs, solutions in MEM sup-
plemented with 10% (v/v) FBS were filtered with a 0.2 µm syringe filter to remove
aggregates formed in the presence of protein. Triplicate measurements were acquired
for each sample. All experiments were carried out with three samples prepared inde-
pendently and measurements were acquired in general purpose mode. Hydrodynamic
diameter measurements were acquired from 12 runs per measurement. Zeta poten-
tial measurements were acquired from 30 runs per measurement. The Smoluchowski
approximation was used to calculate zeta potential from electrophoretic mobility.
2.1.3 Transmission Electron Microscopy
The NP diameter of fluorescent polystyrene NPs measured by the manufacturer with
transmission electron microscopy (TEM) was provided with the certificate of analysis.
For the dark, 60 nm carboxylate-modified and 58 nm amine-modified NPs, the TEM
diameter was measured in the lab of Professor Ingeborg Schmidt-Krey with graduate
student Yusuf Uddin. NP solutions (2 µL; 140 nM unwashed or 14 nM washed)
were spread onto a carbon-coated copper grid (SPI, 2040C, 400 mesh), incubated
for one minute, and blotted with filter paper (Whatman-4). The grids were stained
with 2% (w/v) uranyl acetate (Ted Pella Inc., 19481) for 30 seconds and the uranyl
acetate was removed by blotting. Grids were screened with a TEM (JEOL, JEM-
1400) operated at an acceleration voltage of 120 kV. Images were acquired using both
a Gatan Orius SC1000 CCD camera and an Ultrascan 1000 CCD camera at between
60,000x to 150,000x magnification. The mean diameter was determined using the
ImageJ measure tool on >100 NPs for unwashed NPs in MEM, between 37-41 NPs
for washed NPs after incubation in MEM, and between 66-84 NPs for washed NPs
after incubation in MEM supplemented with BSA. The feret diameter, or diameter
along the longest axis, is reported. A histogram of NP diameters was plotted with 2
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nm binning for the unwashed NPs in MEM and fit to a Gaussian distribution.
2.2 Gel Electrophoresis
2.2.1 Polyacrylamide
Washed NPs were used for all polyacrylamide gels. For the fluorescent polystyrene
and gold NPs, the supernatant was collected after each wash. After the final wash,
the sample was suspended in either buffer containing 6% (w/v) SDS, (New England
Biolabs, B7703S) to remove the protein from the NP surface, or in water. Supernatant
solutions were diluted by 50% (v/v) in Laemmli buffer (Boston Bioproducts, BP-
110R), boiled for 5 min, and loaded onto the gel. The supernatant from the first wash
was diluted to 10% (v/v) for polystyrene and 1% (v/v) for gold NPs. The second
supernatant was diluted to 10% (v/v) for the gold NPs due to the high protein
concentration. Proteins were separated, along with a 5-225 kDa molecular weight
marker (Lonza, 50547), on a 4-20% gradient gel (polystyrene NPs, Bio-Rad 456-
1094) or a 12% mini-protean gel (gold NPs, Bio-Rad, 456-8044) run for 1-2 hours at
40 mA and 130 V. For better separation, the gel was run at a lower voltage (60-90 V)
for the first 20 minutes to allow the protein solution to load evenly into the stacking
gel. Proteins were stained with Simply Blue Safe Stain (Invitrogen, LC6060) for one
hour and destained in water overnight. Polyacrylamide gels were imaged with either
a Canon scanner (CanoScan LiDE 200, 1200 dpi) or an Odyssey imaging system
(Li-Cor Classic 9120, 0.5 mm depth, 700 nm excitation).
2.2.2 Agarose
QDs (0.8 µM) were incubated with water, MEM, or MEM supplemented with 10%
FBS for 10 minutes before loading onto a 1% (w/v) agarose gel. A 5X Tris-Borate-
EDTA (TBE) buffer stock was prepared with 0.45 M tris(hydroxymethyl)aminometh-
ane, 0.45 M boric acid, and 10 mM ethylenediaminetetraacetic acid, pH 8.3. The
agarose gel was cast with a 1X TBE buffer using microwave heating to dissolve the
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solid agarose. Glycerol was added to the QD solutions to aid in well loading. QDs
were separated on the gel in 0.5X TBE buffer for 1 hour and 30 minutes at 90 V
with constant voltage, and a handheld UV light was used to image migration of
the QDs during separation. The gel was imaged on a GE Healthcare Typhoon Trio
scanner (Model 9410, excitation: 488 nm; emission: 520/40 nm bandpass filter; 25
µm resolution).
2.3 Cell Culture
African green monkey kidney epithelial cells (BS-C-1, ATCC), human cervical car-
cinoma cells (HeLa, ATCC), and Chinese hamster ovary cells (CHO, ATCC) were
maintained in a 95% humidity, 5% carbon dioxide atmosphere at 37 ◦C in MEM
(Invitrogen, 61100061) with 10% (v/v) FBS. CHO cells were maintained in Ham’s
F-12 (F-12, Invitrogen). Cells were passaged every 2-4 days using trypsin (Invitrogen,
25200072) to detach adherent cells. From the absorption spectrum of FBS, using the
extinction coefficient of BSA (43,824 M−1·cm−1), the total protein concentration in
10% (v/v) FBS is approximately 10 mg·mL−1. For fluorescence microscopy and flow
cytometry, cells were grown in 35 mm glass-bottom cell culture dishes (MatTek).
Cells used for gold NP experiments were seeded in 12-well plates (Falcon, 353043)
24 hours prior to cellular binding studies. For dark field imaging, cells were grown on
circular glass cover slips (Fisher Scientific, 12-545-100) in 12-well plates. Cover slips
were pre-treated with collagen (Roche, 11179179001) to aid in cellular adhesion. A
stock solution was prepared with 10 mg collagen dissolved in 0.2% (v/v) sterile acetic
acid. The collagen stock solution was diluted in a ratio of 1:50 (v/v) in PBS with
calcium and magnesium and ∼500 µL was incubated with the cover slip for between
30 minutes to 2 hours at 37 ◦C. After incubation, the collagen solution was removed
from the well plate and the cover slip was allowed to air dry under sterile conditions.
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For transport studies, BS-C-1 cells stably expressing the lysosome-associated mem-
brane protein-1 (LAMP1) fluorescently labeled with enhanced yellow fluorescent pro-
tein (EYFP) were used. The LAMP1-EYFP plasmid (Addgene, 1816) contains G418
resistance and was initially transfected with Fugene6 (Roche, 11805091001). The BS-
C-1 cells expressing LAMP1-EYFP were cultured in medium supplemented with 400
µg·mL−1 G418 sulfate (CalBioChem, 345810).
2.4 Fluorescent Labeling
2.4.1 Protein Labeling
BSA was fluorescently labeled with AlexaFluor647 (AF647, Invitrogen, A2006) ac-
cording to previous protocols and consistent with the manufacturers guidelines.3
Briefly, an aqueous BSA solution (10 mg·mL−1 stock) was combined with AF647
(10 mg·mL−1 stock, DMSO) in a 10:1 (v/v) ratio of BSA to AF647 in a sodium
bicarbonate buffer (0.1 M, pH 8.3-9.0). The solution was gently shaken via vortex
for 1 hour at room temperature, and the reaction was quenched with 1.5 M hydrox-
ylamine (pH 8.5). Immediately after quenching, the final product was filtered on a
NAP5 size exclusion column to remove unbound AF647. The final concentrations
were determined with UV-Vis absorption spectroscopy (εBSA = 43,824 M
−1·cm−1 at
275 nm; εAF647 = 239,000 M
−1·cm−1 at 647 nm. The final ratio of AF647 dyes per
protein was between 2-3. A correction factor of 0.03 was used to subtract the AF647
absorbance contribution at 275 nm. The AF647 λmax value was used to discriminate
between AF647-protein conjugates and free AF647. The λmax value of free AF647 is
647 nm, while AF647 conjugated to protein is between 650-652 nm.
2.4.2 Immunofluorescence
For transport studies, the LAMP1 protein was immunofluorescently labeled with Cy5.
The BS-C-1 cells stably expressing LAMP1-EYFP could not be used for NP transport
experiments due to overlap of the EYFP and NP emission. After NP incubation, cells
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were washed twice with PBS with calcium and magnesium (Invitrogen, 14040182) and
fixed for 30 minutes in 4% (v/v) H2CO (Thermo Scientific, 28908, 16% (v/v) stock
solution) in PBS. The cells were then rinsed twice with PBS, and immunostained to
fluorescently label the LAMP1 protein and identify lysosomal vesicles. All immunos-
taining steps were performed in a 1 mL solution volume while gently rocking, and cells
were rinsed twice in wash buffer (0.3% w/v BSA and 0.1% v/v octyl phenol ethoxylate
(Triton-X, JT Baker, X198-05) in PBS) between permeabilization and after incuba-
tion of primary and secondary antibodies. Cells were permeabilized for 15 minutes
(3% (w/v) BSA, 10% (v/v) FBS, 0.5% (v/v) Triton-X in PBS) and incubated for 1
hour in blocking buffer (3% (w/v) BSA, 10% (v/v) FBS in PBS). To fresh blocking
buffer, the LAMP1 primary antibody (mouse, Abcam, ab25630) was added to a final
antibody concentration of 1 µg/mL and incubated overnight (minimum of 12 hours)
at 4 ◦C. After a second blocking step, secondary antibody (rabbit anti-mouse-Cy5,
Chemicon, AP160S) was added to a final concentration of 2.5 µg/mL and incubated
for 2 hours at room temperature. The final wash step prior to imaging was done in
PBS and imaging was done in 1 mL PBS. Control experiments were completed in par-
allel for every immunostaining experiment consisting of cells incubated with primary
antibody alone and secondary antibody alone. All other steps were kept constant,
and these control plates were imaged with the immunostained plates to determine
laser power and detector voltage thresholds.
2.5 Microscopy
2.5.1 Wide Field Fluorescence
For cellular binding experiments, cells were cooled to 4 ◦C on ice for 10 minutes. NPs
and QDs were incubated with cells for 10 minutes, and LDL-DiD was incubated with
cells for 30 minutes at 4 ◦C by adding the NPs directly to 1 mL of MEM, MEM
supplemented with 10% (v/v) FBS, or MEM supplemented with 10 mg·mL−1 BSA.
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Cells were rinsed twice with PBS with calcium and magnesium to remove unbound
NPs. Cells were either imaged in 1 mL PBS immediately or after fixing with 4%
(v/v) H2CO in PBS. NP binding to cells was imaged with a fluorescence microscope
(Olympus, IX71) using a 60x, 1.20 numerical aperture (N.A.), water immersion ob-
jective (Olympus). Fluorescence emission was collected with an electron multiplying
charge-coupled device (EMCCD) camera (Andor, DU-897). Multiple fluorophores
in the same spatial location were imaged by acquiring multiple images at the same
focus but with different filter sets. Images for comparison were collected with the
same exposure time and EM gain. Both were optimized for each experiment but were
usually in the range of a 100 - 200 ms exposure time and an EM gain of 2. Nuclei
were stained with 27 µM 4,6-diamidino-2-phenylindole dilactate (DAPI, Invitrogen,
D35671) at 37 ◦C for 30 minutes to 1 hour. The following bandpass and dichroic
filters were used for imaging: nuclear staining with DAPI (excitation: 387/11; emis-
sion: 447/60; Semrock, DAPI-1160A), NPs and QDs (excitation: 480/40, Chroma;
dichroic: FF506-Di02, Semrock; emission: 536/40, Semrock), and LDL-DiD (excita-
tion: 620/60, Chroma; dichroic: FF660-Di01, Semrock; emission: 692/40, Semrock).
2.5.2 Confocal Fluorescence
Cellular transport experiments were imaged with a laser scanning confocal microscope
(Olympus, Fluoview 1000) and a 60x, 1.42 N.A., oil immersion objective (Olympus).
Vesicles positive for LAMP1 were used as the endpoint for endocytic cellular trans-
port. BS-C-1 cells were incubated with BSA-AF647 (final BSA concentration: 2.2
µM) or BSA-NP complexes (final BSA concentration: 0.12 µM; final NP concen-
tration: 0.034 nM) at 37 ◦C for between 10 minutes and 18 hours. To form the
BSA-NP complexes, unlabeled BSA was incubated with the NPs for 20 minutes be-
fore adding to cells. BSA-AF647 transport was imaged in the LAMP1-EYFP BS-C-1
cells, and BSA-NP transport was imaged in BS-C-1 cells with immunofluorescently
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labeled LAMP1-Cy5. A 150 µm confocal aperture and 12.5 µs dwell time was used to
acquire all fluorescence images. Fluorescence was recorded on photomultiplier tubes
(PMTs) and final images were acquired with Kalman averaging on 10 successive im-
ages. NPs and EYFP were excited with the 488 and 515 nm lines of an argon ion
laser, respectively. Both AF647 and Cy5 were excited with a 635 nm diode laser. NP
emission was collected with a 505-605 nm bandpass filter, YFP with a 535-565 nm
bandpass filter, and both Cy5 and AF647 emission were collected with a 655-755 nm
bandpass filter. Shorter wavelength emission was separated from longer wavelengths
with a 640 nm dichroic mirror. Comparative images in a series were imaged with
the same respective laser power and PMT voltages. Quantification of colocalization
between BSA-AF647 and BSA-NP with LAMP1 positive vesicles was done using the
ImageJ Image5D plugin. A 100 µm2 grid was placed over the image and ∼1 vesicle per
grid square was analyzed, avoiding the perinuclear region where vesicle aggregation is
common. Vesicles positive for LAMP1 were identified in the single channel images to
avoid bias for vesicles colocalized with BSA-AF647 or BSA-NP. Final colocalization
numbers were acquired by analyzing 20 vesicles per cell on ≥6 cells from ≥2 unique
cell passage numbers. Mean and standard deviation values per cell are reported.
2.5.3 Dark Field
Cellular binding of gold NPs used the same protocol as fluorescent NPs, except that
the NPs were incubated for 30 minutes with cells grown on circular cover slips. After
rinsing with PBS, cells were fixed with 4% (v/v) H2CO. Images were acquired from
cells sealed between the circular cover slip and a second clean cover slip. A small
amount of glycerol was added between the cover slips to prevent drying. Dark field
images were acquired using both an inverted microscope (Olympus, IX70) in the lab
of Professor Mostafa El-Sayed4 and an upright microscope (Olympus, BX51) on a
setup built in our lab (Chapter 7.2.3). A 100x, 0.5 - 1.35 variable N.A., oil immersion
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iris objective (Olympus, UPlanApo) and a 1.2 N.A. dark field condenser (Olympus,
U-DCW) were used for imaging and a Nikon digital camera (D200) attached to either
the front port (inverted) or top port (upright) of the microscope was used to image
scattered light.
2.6 Binding Competition Assays
2.6.1 Flow Cytometry
Binding competition studies used FBS and BSA as competitors for serum protein
receptors. Fucoidan (Sigma-Aldrich, F5631) and polyinosinic acid (Sigma-Aldrich,
P4154) were used as competitors for scavenger receptors. Polyadenylic acid (Sigma-
Aldrich, P9403) was used as a control. The competitor or control molecule was incu-
bated with cells for 20 minutes at 4 ◦C in MEM for carboxylate-modified polystyrene
NPs, QDs, and LDL, or in MEM supplemented with either 10% (v/v) FBS or 10
mg·mL−1 BSA for amine-modified NPs. The NPs were then incubated with cells in
the presence of the competitor molecule for 10 minutes. Cells were rinsed twice with
PBS with calcium and magnesium to remove unbound NPs, twice with PBS without
calcium and magnesium, and incubated in 10 mM ethylenediaminetetraacetic acid
(Mallinckrodt, 49310-04) for 30 minutes at 37 ◦C to remove adherent cells from the
culture dishes. The solution in the cell culture dish was pipetted across the bottom
of the dish several times to detach the cells completely, and the cell suspension was
transferred to a microcentrifuge tube. Cells were rinsed twice with Leibovitz’s L-15
buffer (Invitrogen, 21083027) via centrifugation at 10,000g for 10 minutes, filtered
with a 40 µm cell strainer (BD Falcon, 352340), and kept on ice for one hour prior to
analysis with flow cytometry (BD Biosciences, LSR-II). Data was collected for 10,000
live cells in each sample. The dead cell population was distinguished with propidium
iodide staining. Cells alone in the absence of NPs, using the same conditions and
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PMT voltages used in competition studies, were also measured to determine the con-
tribution from cellular autofluorescence. A 488 nm laser was used to excite the NPs
and QDs, and fluorescence emission was collected on a 530/30 nm bandpass filter.
LDL and BSA-AF647 fluorescence was excited with a 633 nm laser, and emission was
collected on a 660/20 nm bandpass filter. Scatter plots and fluorescence histograms
were analyzed with the Weasel software (Walter and Eliza Hall Institute of Med-
ical Research, Victoria, Australia, version 3.0.1). The mean fluorescence intensity
calculated from the histograms was used to quantify fluorescence.
2.6.2 Differential Absorbance
Cellular binding competition studies of gold NPs used the same conditions as for dark
field microscopy, except that cells were grown in 12-well plates rather than on glass
cover slips. To prevent gold NP aggregation, 0.17 nM gold NPs were incubated with
0.5% (v/v) FBS for 20 minutes to form protein-gold NP complexes before adding to
MEM. Competitors, including 10% (v/v) FBS and 10 mg·mL−1 BSA, were incubated
with cells at 4 ◦C in colorless MEM for 10 minutes prior to addition of protein-
gold NP complexes and were present during NP incubation. After incubation, the
supernatant solution above the cell monolayer was transferred to a 96-well plate
and absorption spectra were recorded between 300 and 700 nm with a SpectraMax
plate reader (Molecular Devices, M2e). The maximum absorbance at 524 nm due to
absorption by the gold NP localized surface plasmon resonance was baseline corrected
and subtracted from the absorbance value of gold NPs in the absence of cells. The





UV-Vis absorption spectra were measured on a spectrophotometer (Beckman-Coulter,
DU-800) with a scan speed of 1200 nm·minute−1 and 1.0 nm wavelength interval.
Spectra were acquired between 200 and 800 nm with a 1 cm path length, UV silica
cuvette (Beckman Coulter, 523450).
2.7.2 Fluorescence
Fluorescence spectra were acquired on a spectrofluorophotometer (Shimadzu, RF-
5301) with a 3 x 3 mm light path cuvette (Hellma, 105.254-QS) and a 1 nm sampling
interval. Samples were excited at 280 nm and emission was collected between 250 and
500 nm using 5 nm slit widths for both the excitation and emission monochromaters.
All solutions were prepared in 10% (v/v) PBS without calcium and magnesium. BSA
(9.8 µg·mL−1) was measured in the presence of non-fluorescent 60 nm carboxylate-
modified and 58 nm amine-modified NPs. Working NP concentration ranged from
0.067 nM to 0.53 nM. Experiments were repeated in triplicate. Corrected spectra are
the raw spectra with the NP scatter peak and buffer contribution subtracted out, and
the initial emission value at 250 nm set to zero. The Stern-Volmer relationship was
used to determine the equilibrium constant (Equation 3).
Fo
F
= 1 +KSV [NP ] (3)
The fluorescence intensity ratio of BSA at λmax in the absence (F o) and presence
(F ) of a quencher was calculated and plotted versus the NP quencher concentration
([NP]). The first four points were used in a linear fit of the data, and the slope of
the line is equal to an effective Stern-Volmer equilibrium constant (K SV , M
−1). The




Circular dichroism (CD) spectra were acquired on an Olis CD spectrophotometer with
the sample chamber maintained at 20 ◦C. Measurements were made using a 0.5 mm
path length quartz cell (Starna, 20/O-Q-0.5). The bandwidth was set to 2 nm and the
integration time was a function of the PMT voltage. Samples were measured in 10%
(v/v) PBS without calcium and magnesium. Buffer alone without protein was used as
a blank. BSA (0.098 mg·mL−1) and holo-transferrin (0.049 mg·mL−1, Sigma, T1283)
were measured alone and in the presence of 60 nm carboxylate-modified NPs (0.4 nM)
and 58 nm amine-modified NPs (0.4 nM). BSA was also measured in the presence
of 200 nm carboxylate-modified NPs (13 pM) and 200 nm amine-modified NPs (13
pM). The NP concentration was optimized to reduce scatter and absorbance from the
NPs. Samples with BSA were incubated for 10 minutes prior to acquisition and all
spectra are an average of 10 consecutive scans. All measurements were repeated in
triplicate. Spectra were smoothed with a Savitzy-Golay least-squares fitting6 (digital
filter = 13) and the value at 260 nm was set to zero to account for spectral drift.






The mean residue ellipticity ([θ]), in units of degrees·cm2·dmol−1, is a function of
the observed signal in millidegrees, [θ]obs, the average molecular weight of the protein
(MW ), path length in cm (l), protein concentration in g·L−1 (C ), and the total
number of amino acids (n). BSA has a molecular weight of 66,430 g·mol−1 and 583
total amino acids.7 The approximate molecular weight and total number of amino
acids in bovine holo-transferrin are 79,000 and 660, respectively (Sigma-Aldrich). The
percentage of α-helices was calculated from Equation 5.
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%α− helix = −[θ]MRE − 4, 000
33, 000 − 4, 000
(5)
The α-helicity of a protein is a function of the mean residue ellipticity at 208 nm
([θ]MRE), minus the contribution from the β-form and random coil conformations at
208 nm (4,000). The observed value is compared to the mean residue ellipticity of a
pure α-helix protein (33,000).
2.8 Isothermal Titration Calorimetry
Isothermal Titration Calorimetry (ITC) measurements were made on a Nano ITC
(TA Instruments, low volume) at 25 ◦C with a constant stirring speed of 250 rpm.
For all titrations, sixteen 3 µL injections were made with a 300 second equilibration
time before and after each injection. All solutions were prepared in a 20 mM HEPES
buffer (pH 7.4). Titration of BSA (75 µM) alone into buffer was subtracted injection-
by-injection from BSA titrations into NP solutions. The 60 nm carboxylate-modified
NPs (0.005 nM) or 58 nm amine-modified NPs (1.4 nM) were loaded into the sample
cell. NP and protein concentrations, along with the buffer, were optimized such
that BSA saturation and equilibrium was achieved. The baseline between peaks was
selected manually. Integration of differential power plots as a function of time gave
binding curves, and the raw data was fit with the one independent site model using
the NanoAnalyze software (TA Instruments, version 2.4.1).8 The first injection was
excluded from the fit. Each titration curve was repeated 3-4 times. The theoretical
monolayer coverage of BSA molecules per NP was calculated using the assumption




All experiments were repeated, at minimum, in triplicate. Mean and standard devia-
tion are reported for all numerical values. Error bars represent the standard deviation.
Significance and p-values were determined using a two-tailed, two-sample indepen-
dent t-test. Numerical analysis and quantification (e.g. colocalization methods) are
described in the respective subsection. All images were analyzed with ImageJ soft-
ware version 1.43u (http://rsb.info.nih.gov/ij/). Images for comparison were set to
equal brightness and contrast.
2.9.1 Modeling
Protein structures were rendered using the visual molecular dynamics modeling pro-
gram developed with NIH support by the Theoretical and Computation Biophysics
group at the Beckman Institute, University of Illinois at Urbana-Champaign. Electro-
static surface maps of proteins were created using eF-surf (http://ef-site.hgc.jp/eF-
surf/top.do) for BSA (PDB: 4F5S) and transferrin (PDB: 3QYT).
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CELLULAR BINDING OF CHARGED NANOPARTICLES
3.1 Introduction
Nanoparticles (NPs) used in biomedical applications will be exposed to the complex
biological milieu containing a diverse mixture of extracellular proteins. For example,
NPs injected directly into the blood stream will encounter thousands of unique pro-
teins present in serum.1–3 These proteins rapidly adsorb onto the NP surface forming
a protein “corona.”4–6 We have previously observed that serum proteins remain bound
to the NP surface during both cellular binding and internalization7,8. Importantly,
it is the proteins adsorbed on the NP surface, rather than the NP, that mediate NP
interactions with cells. Many serum proteins have dedicated cellular binding sites,9–12
suggesting that serum proteins can influence cellular binding of NPs both by the for-
mation of a protein-NP complex and subsequently by competing with the NPs for
cellular receptors. NPs designed for use in biological systems require characterization
in a realistic environment, representative of what the NP will encounter through the
course of application.
While many NP properties can alter the composition and dynamics of protein
adsorption to the NP surface, of specific interest has been the role of NP surface
charge. NPs used in biology and medicine often have a charged surface, either as a
result of the NP synthesis or from the intentional addition of surface ligands. Charged
functional groups screen the high energy surface of the NP from other NPs or cells in
proximity, and aid in the direct interaction of NPs with cells and cellular receptors.13
A general picture has emerged suggesting that neutral or negatively charged NPs help
to shield NPs from adsorption of negatively charged serum proteins, but have a low
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affinity for the negatively charged binding sites on the plasma membrane.13,14 In com-
parison, positively charged NPs risk adsorption of anionic serum proteins, but readily
bind and are internalized by anionic proteoglycans on the cell surface.15 The physi-
cal reality is much more complex as anionic polystyrene,4,16,17 citrate-modified gold
NPs,18 and polyacrylic acid-modified gold nanorods19 have all been shown to form
complexes with serum proteins. Many proteins contain both positive and negative
residues at physiological pH, regardless of their net charge, allowing for electrostatic
adsorption to both cationic and anionic surfaces. Surface plasmon resonance stud-
ies of gold surfaces show that albumin, a highly abundant serum protein,1–3 binds
more readily to anionic carboxylate-modified surfaces than cationic amine-modified
surfaces, likely due to the presence of multiple positively charged lysine residues.20
Cellular binding is the first step in the interaction of NPs with cells. Binding
mediates NP entry into cells and can subsequently determine the cellular transport
pathway. Our goal was to determine how the cellular binding of cationic and anionic
NPs is affected by extracellular serum proteins. We studied cellular binding indepen-
dent of internalization to isolate the effect of serum proteins on NP binding to the
cell surface. To address this question, we carried out a side-by-side comparison of
the cellular binding of NPs in the presence of serum proteins using NPs of the same
composition but with opposite initial surface charge.21 Using gel electrophoresis and
dynamic light scattering measurements, we observed that both cationic and anionic
NPs formed protein-NP complexes when exposed to serum proteins. While the pres-
ence of serum proteins enhanced the cellular binding of cationic NPs, serum proteins
inhibited the binding of anionic NPs. We determined that this difference in cellular
binding is due to the cellular receptors used by the protein-NP complexes. Fluores-
cence microscopy and flow cytometry were used to characterize and quantify cellular
binding trends. Protein-NP complexes formed from cationic NPs bind to scavenger
receptors on the cell surface. In comparison, the protein-NP complexes formed from
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anionic NPs compete with serum proteins in solution for native protein receptors. As
NPs are increasingly important for in vivo applications, we anticipate these results
will inform the design of NPs with improved cellular binding.
3.2 Results and Discussion
In the course of experiments we used cationic, amine-modified polystyrene NPs and
anionic, carboxylate-modified polystyrene NPs (Fluospheres, Invitrogen). Within our
lab, the hydrodynamic diameter (dh) and zeta potential (ZP) of the NPs was measured
using a Malvern Zetasizer (Table 2). NPs were diluted in water and measurements
were carried out in triplicate. The NP diameter measured with TEM (dTEM) was
supplied by Invitrogen and is also provided in Table 1. Throughout the text we use
the diameter provided in the catalog to refer to the NP. For example, carboxylate-
modified NPs with a dTEM of 45 nm and a dh of 60 nm are described as 40 nm
NPs.
Table 2: TEM diameter (dTEM), hydrodynamic diameter (dh), and zeta potential
(ZP) of the NPs used in the course of experiments
NPs dTEM (nm)
a dh (nm) ZP (mV)
87 nm NH2 87 ± 6 152.7 ± 3.2 39.2 ± 3.6
200 nm NH2 200 ± 11 270.1 ± 9.3 19.9 ± 3.4
40 nm COOH 45 ± 6 60.04 ± 0.91 -43.3 ± 1.5
200 nm COOH 210 ± 10 236.2 ± 3.3 -31.0 ± 1.6
aTEM data provided with certificate of analysis from Invit-
rogen.
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3.2.1 Cationic and Anionic NPs Form Protein-NP Complexes
We first determined whether both cationic and anionic NPs would form protein-NP
complexes when exposed to extracellular serum proteins. Cells are typically cul-
tured in an aqueous solution of amino acids, vitamins, inorganic salts, and glucose,
described as the medium, which is generally supplemented with serum.22 Minimum
Essential Medium (MEM) supplemented with 10% (v/v) fetal bovine serum (FBS) is
commonly used for cell culture, and we used this mixture as a representative biological
environment. A combination of gel electrophoresis, zeta potential, and hydrodynamic
diameter measurements were used to characterize the NPs after incubation in MEM
supplemented with 10% (v/v) FBS. The cationic NPs are expected to bind to net
anionic serum proteins as previously observed with zeta potential measurements and
fluorescently-labeled serum proteins.7,8 This was confirmed by incubating the 200 nm
amine-modified NPs (15 pM) with MEM supplemented with 10% (v/v) FBS for 10
minutes at 4 ◦C, identical to the conditions used in cellular experiments. The so-
lution of NPs and serum proteins was then centrifuged (16,000g, 10 minutes) and
resuspended in water 6 times. After each wash the supernatant was collected, run
on an polyacrylamide gel (4-20% gradient), and stained with Simply Blue Safe Stain
for 1 hr. The first supernatant contained the highest protein concentration and was
diluted to 10% (v/v) to avoid overloading the gel. A gel run under similar conditions
but without dilution of the supernatant is shown in Figure 2 for comparison. After
5 washes, no protein was detected in the supernatant demonstrating that unbound
protein had been removed from the NP-protein mixture. The NPs were then resus-
pended in a solution of 6% (w/v) sodium dodecyl sulfate (SDS), a detergent that is
expected to remove any proteins that remain bound to the NP. Following resuspen-
sion in SDS, a protein band at ∼66 kDa is visible in the gel (Figure 1A, NP + SDS).
In the absence of SDS, no protein is visible (NP + H2O). This demonstrates that
incubation in MEM supplemented with 10% (v/v) FBS results in the adsorption of
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proteins on the 200 nm cationic NPs.
The protein-NP complex that remained following the final wash, in the absence of
SDS, was used for zeta potential and hydrodynamic diameter measurements (Figures
1B and 1C). These measurements show that the protein-NP complex formed with the
cationic NPs becomes anionic (-19.4 mV ± 1.8 mV) and increases in diameter (365.1
nm ± 39.8 nm). Similar results were obtained for the 87 nm amine-modified NPs
although these NPs were more difficult to pellet resulting in greater conductivity and
polydispersity (Figure 3).
We next determined whether the 200 nm anionic NPs formed a protein-NP com-
plex, similar to the cationic NPs, or if they were resistant to protein adsorption and
remained bare NPs in the presence of FBS. The adsorption of serum proteins on the
anionic NPs was investigated using gel electrophoresis, zeta potential, and hydrody-
namic diameter measurements as described for the cationic NPs. Like the cationic
NPs, protein was detected on “washed” anionic NPs following gel electrophoresis and
SDS treatment (Figure 1D, NP + SDS). The first supernatant (S1) was again diluted
by 10% (v/v). The charge of the anionic NPs increased to -26.5 mV ± 2.5 mV (Figure
1B), more similar to the zeta potential of BSA (-22 mV, data not shown), and the
diameter of the NP increased (410.2 nm ± 38.8 nm, Figure 1C). This demonstrates
that exposure to FBS results in the adsorption of proteins on the 200 nm anionic NPs,
in good agreement with previous results showing the adsorption of serum proteins on
100 nm carboxylate-modified polystyrene NPs.16 The 40 nm carboxylate-modified
NPs were too small to pellet and could not be analyzed after washing.
Using three different methods, we have shown that serum proteins remain bound
to both cationic and anionic NPs following multiple wash steps that remove free and
weakly bound proteins. Based on the molecular weight of the protein removed in the
SDS wash (Figures 1A and 1D), it is likely that BSA is the main protein adsorbed
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200 nm NH2 200 nm COOH
Figure 1: Formation of a protein-NP complex confirmed with gel electrophoresis,
zeta potential, and hydrodynamic diameter. (A) Gel electrophoresis of supernatants
(S) following repeated centrifugation and wash steps of the 200 nm amine-modified
NPs. NPs were incubated in either SDS (NP + SDS), to remove the protein corona,
or water (NP + H2O). Molecular weight (MW) marker shows 225, 150, 100, 75, 50,
35, 25, 15, 10, and 5 kDa. FBS, in the absence of NPs, is shown for comparison.
(B) Zeta potential of NPs incubated in MEM supplemented with FBS after six wash
steps. (C) Hydrodynamic diameter after six wash steps. (D) Gel electrophoresis of
the 200 nm carboxylate-modified NPs using the same procedure as in (A).
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Figure 2: Gel electrophoresis of undiluted supernatants (S) of 200 nm carboxylate-
modified NPs incubated in MEM supplemented with FBS following each wash step.
SDS removes bound protein from the NP (NP + SDS, white box) whereas water does
not (NP + H2O). Molecular weight (MW) marker shows 225, 150, 100, 75, 50, 35,
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Figure 3: Formation of a protein-NP complex on 87 nm amine-modified NPs after
four wash steps via centrifugation and resupension in water. (A) Hydrodynamic
diameter. (B) Zeta potential.
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approach. This is an interesting result as it shows both cationic and anionic NPs
form a protein-NP complex. The protein-NP complex formed from both cationic
and anionic NPs appears to be similar: both types of NPs are net anionic following
exposure to 10% (v/v) FBS and both form a corona of mainly BSA.
3.2.2 Cationic NP Binding is Enhanced by Serum Proteins
To compare the cellular binding of the protein-NP complexes formed from the cationic
and anionic NPs, we examined the cellular binding of the NPs in the presence and
absence of excess serum proteins. We first compared the cellular binding of NPs in
MEM, which lacks proteins, to MEM supplemented with 10% (v/v) FBS. Cells were
cooled to 4 ◦C for 20 minutes before the addition of NPs and were maintained at 4 ◦C
during 10 minutes of incubation with the NPs. At 4 ◦C NP internalization is blocked,
allowing us to image cellular binding independent of internalization.23–28 After 10
minutes at 4 ◦C, cells were rinsed twice with phosphate buffered saline (PBS) and then
imaged using fluorescence microscopy. The concentration of NPs incubated with the
cells is provided. We find that the 87 nm cationic NPs (34 pM) have minimal binding
to cells in the absence of FBS and significant binding in the presence of FBS (Figure
4A). A similar increase in binding was observed for 200 nm cationic NPs (15 pM)
in the presence of FBS (Figure 4B). We propose that the lower zeta potential of the
200 nm NPs results in greater direct interaction with the plasma membrane, possibly
via hydrophobic interactions, in the absence of FBS. These results demonstrate that
the formation of a protein-NP complex enhances the cellular binding of cationic NPs.
Enhanced binding in excess FBS suggests that the protein adsorbed on the NP is
responsible for cellular binding and that this protein-NP complex does not compete
with free proteins in solution for cellular binding sites.
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Figure 4: Fluorescence microscopy images of NPs (green) bound to BS-C-1 cells at 4
◦C in MEM and MEM supplemented with FBS. Nuclei are stained with DAPI (blue).
Cationic NPs are amine-modified and anionic NPs are carboxylate-modified.
3.2.3 Anionic NP Binding is Inhibited by Serum Proteins
Unlike the cationic NPs, the cellular binding of both the 40 nm (26 pM) and 200
nm (13 pM) anionic NPs was inhibited by the addition of serum proteins (Figures
4C and 4D). As the anionic NPs form a protein-NP complex when exposed to FBS
(Figure 1), it is the cellular binding of this protein-NP complex that is inhibited by
the excess serum proteins in solution. This suggests that the protein-NP complex
formed from the anionic NPs competes with the free proteins in solution for cellular
binding sites. Our results are in good agreement with recent experiments that showed
the cellular uptake of 49 nm and 100 nm anionic polystyrene NPs is inhibited by the
presence of serum proteins.29 Based on our results, which distinguish cellular binding
from uptake, it is likely that decreased binding of anionic NPs in the presence of
serum proteins led to the observed decrease in uptake. In addition, the results for
polystyrene NPs are in good agreement with previous work showing that the cellular
53
uptake of gold NPs functionalized with DNA or siRNA is inhibited by the presence
of serum proteins.30 Like the carboxylate-modified polystyrene NPs, the DNA- and
siRNA-modified gold NPs are anionic suggesting the reduced binding in the presence
of serum proteins may be due to NP charge rather than composition.
While the conventional view has been that anionic NPs have fewer cellular binding
sites and limited uptake compared to cationic NPs,13 previous reports of the cellular
binding of NPs as function of charge provide a conflicting picture. For example, 18
nm gold NPs modified with a cationic polymer were found to enter adenocarcinoma
breast cells (SK-BR-3) to a much greater extent than the same NPs with a negative
surface charge.14 Similar results were obtained for ∼100 nm polymer NPs in adeno-
carcinoma human cervical cells (HeLa).31 In comparison, the uptake of cerium oxide
NPs by adenocarcinoma lung cells (A549) was found to be much greater for anionic
NPs.32 Similarly, high uptake of anionic 35 nm iron oxide NPs was observed for HeLa
cells.33 While some variation may be due to differences in cell type, similar trends
are expected for non-phagocytic cells. Based on our results (Figure 4), it is clear
that differences in NP binding are highly dependent on the presence or absence of
serum proteins: serum proteins enhance the binding of cationic NPs and inhibit the
binding of anionic NPs. Interpretation of previous results examining cellular binding
and uptake as a function of charge is often difficult because it is not clear from pub-
lications if FBS or other serum proteins were present. In addition to the presence
of serum proteins, the concentration of NPs is an important factor for cellular bind-
ing. Repeating the experiments described above using much higher concentrations
of NPs, we find that the observed trends no longer hold (Figure 5). When the NP
concentration reaches a high enough threshold, cationic NPs can bind to cells in the
absence of FBS and anionic NPs can bind in the presence of FBS. It is important to
note that NP concentration may be one factor responsible for seemingly conflicting
























[26 pM] [311 pM]
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Figure 5: Effect of NP concentration on cellular binding to BS-C-1 cells in MEM
(cationic NPs) and MEM supplemented with FBS (anionic NPs).
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3.2.4 Cellular Binding Trends are Independent of Cell Type
As cellular binding studies have been reported in the literature for several cell types,
it is important to consider the variable of the cell surface. To determine if the trends
we observe are dependent upon cell type, we repeated cellular binding experiments
with polystyrene NPs in multiple cell lines. Initial experiments were performed with
green African monkey kidney epithelial (BS-C-1) cells. Cellular binding experiments
with polystyrene NPs were repeated in HeLa cells. Cationic, 87 nm (84 pM) and 200
nm (150 pM) amine-modified polystyrene NPs, and anionic, 40 nm (26 pM) and 200
nm (26 pM) carboxylate-modified polystyrene NPs were incubated with HeLa cells
for 10 minutes at 4 ◦C in MEM and MEM supplemented with 10% (v/v) FBS. The
87 nm amine-modified NPs did not bind to cells in MEM alone, but binding was
enhanced in the presence of FBS (Figure 6A). The 200 nm amine-modified NPs did
not bind to HeLa cells at any concentration between 15 and 150 pM (Figure 6B). The
lack of binding may be due to differences in available cell surface receptors between
HeLa and BS-C-1 cells in culture.
We observe that both the 40 nm and 200 nm, carboxylate-modified polystyrene
NPs bind to HeLa cells in MEM alone (Figures 6C and 6D). This is consistent to
what was observed with BS-C-1 cells. The cellular binding for both diameters of
anionic NPs is inhibited in the presence of serum proteins. We also repeated the
same cellular binding experiments using Chinese hamster ovary (CHO) cells (Figure
7), an epithelial-like cell line. Hams F-12 nutrient mixture, the native cell culture
medium for CHO cells, was used instead of MEM for cellular binding experiments.
In CHO cells, the binding of 87 nm amine-modified NPs (17 pM) was enhanced by
serum proteins (Figure 7A), where the 200 nm amine-modified NPs (75 pM) did
not bind to CHO cells (Figure 7B). Both the 200 nm (64 pM) and 40 nm (52 pM)
carboxylate-modified NPs bound to cells in the presence of Ham’s F-12 without serum
proteins (Figures 7C and 7D), and the presence of serum proteins inhibited binding.
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Figure 6: Fluorescence microscopy images of NPs (green) bound to HeLa cells at 4
◦C in MEM and MEM supplemented with FBS. Nuclei are stained with DAPI (blue).
Cationic NPs are amine-modified and anionic NPs are carboxylate-modified.
The binding trends are similar to those observed with both HeLa and BS-C-1 cells,
suggesting that the binding of charged NPs in the presence of serum proteins is not
dependent on cell type or the specific formulation of the cell culture medium.
3.2.5 Protein-NP Complexes Formed from Cationic NPs Bind to Scav-
enger Receptors
Although both cationic and anionic NPs form protein-NP complexes, these protein-
NP complexes have very different cellular binding behavior. In the case of the cationic
NPs, the formation of the protein-NP complex enhances binding. In comparison, the
cellular binding of the protein-NP complex formed with the anionic NPs is inhibited
by the presence of serum proteins in solution. This suggests that the protein-NP
complex formed from anionic NPs competes with a protein present in FBS for the
same binding site, while the protein-NP complex formed from cationic NPs is able to
access a different set of cellular receptors.
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Figure 7: Fluorescence microscopy images of NPs (green) bound to CHO cells at 4 ◦C
in F-12 medium and F-12 medium supplemented with FBS. Nuclei are stained with
DAPI (blue). Cationic NPs are amine-modified and anionic NPs are carboxylate-
modified.
Blood plasma is a complex mixture of hundreds of distinct proteins, the most abun-
dant of which is albumin (55%).1–3 Lower abundance proteins exist but are harder
to detect. The protein composition of serum is similar to plasma with the removal of
clotting factors such as fibrinogen. In the case of FBS, the relevant albumin is bovine
serum albumin (BSA). Albumin has well-characterized cellular receptors responsible
for binding and internalization.9–11 However, it has been shown that chemical mod-
ifications to albumin, including adsorption on the surface of 5 nm gold NPs, alters
the binding site of albumin.34–36 Instead of the cell surface receptors used by albu-
min, modified albumin binds to glycoprotein(gp)30 and gp18, which act as scavenger
receptors.
To determine if scavenger receptors are responsible for the serum protein-dependent
binding of the cationic NPs, we carried out a series of competition assays. Confluent
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monolayers of BS-C-1 cells were incubated with polyinosinic acid in MEM supple-
mented with 10% (v/v) FBS for 20 minutes. This polyanionic molecule is a known
competitor for scavenger receptors.16,30,35 If the NPs, complexed with serum proteins,
bind to scavenger receptors, we expect the addition of polyinosinic acid to compete
with the protein-NP complex for binding sites on the cell surface thereby inhibiting
cellular binding of the NPs.
Flow cytometry was used to measure the NP fluorescence from individual cells.
A representative scatter plot and fluorescence histograms are shown in Figure 8. The
live cell population used in analysis is circled in the scatter plot (Figure 8A). The
choice of this population was based on a propidium iodide assay used to distinguish
live from dead cells. We observed that polyinosinic acid inhibits the binding of the
87 nm cationic NPs in the presence of FBS (Figures 8B and 9A). NP binding is
normalized to 100% in the absence of polyinosinic acid. Fluorescence from cellular
background, in the absence of NPs, is 11%. A control experiment with polyadenylic
acid, a molecule similar in structure that does not compete for binding with scavenger
receptors,30 shows no competition with the 87 nm NPs (Figure 9B). Similar results
were obtained for the 200 nm cationic NPs (Figure 10A). These results demonstrate
that scavenger receptors are important for the cellular binding of the protein-NP
complex formed from cationic NPs.
3.2.6 Protein-NP Complexes Formed from Anionic NPs Bind to
Native Protein Receptors
Unlike the protein-NP complexes formed from cationic NPs, the cellular binding of the
protein-NP complexes formed from anionic NPs is inhibited by the presence of excess
serum proteins (Figures 4C and 4D). This suggests that these protein-NP complexes
compete with proteins present in FBS for cellular binding sites. A competition assay
using the 40 nm anionic NPs in MEM with increasing concentrations of FBS results







Figure 8: Representative flow cytometry data used to generate bar graphs for compe-
tition assays. (A) Forward and side scatter plot showing the cell population used for
analysis (circled). (B) Fluorescence histograms demonstrating that the presence of
increasing concentrations of polyinosinic acid (0 to 250 µg·mL−1) leads to decreased

















































































































Figure 9: Cellular binding competition studies of protein-NP complexes. (A) Cel-
lular binding of 87 nm amine-modified NPs in MEM supplemented with FBS in the
presence of increasing concentrations of polyinosinic acid and (B) polyadenylic acid.
(C) Cellular binding of 40 nm carboxylate-modified NPs in the presence of increasing























































Figure 10: Cellular binding competition studies of 200 nm NPs. (A) 200 nm amine-
modified NPs in MEM supplemented with FBS in the presence of increasing concen-
trations of polyinosinic acid. (B) 200 nm carboxylate-modified NPs in the presence
of increasing concentrations of FBS.
cellular imaging experiments, only minimal binding is observed. Cellular background
in the absence of NPs is 8%. Similar results were obtained for the 200 nm anionic
NPs (Figure 10B). These results indicate that the protein-NP complex formed from
the 40 nm anionic NPs does not bind to scavenger receptors, but instead binds to a
native protein receptor.
To determine if the scavenger receptors play any role in the binding of the bare an-
ionic NPs, we carried out a competition assay in MEM, in the absence of FBS, using
polyinosinic acid as the competitor (Figure 9D). Compared to the 87 nm protein-NP
complex (Figure 9A), cellular binding of the bare 40 nm anionic NPs was minimally
inhibited by the presence of polyinosinic acid and lacked any concentration depen-
dence. These results demonstrate that the bare 40 nm anionic NPs do not require
binding to scavenger receptors. The specific cellular receptor for the bare 40 nm
carboxylate-modified NPs remains unidentified.
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3.3 Conclusions
We have determined that the binding of NPs to the cell surface in the presence of
extracellular serum proteins is highly dependent on the charge of the NP. Although
serum proteins adsorb onto the surface of both cationic and anionic NPs in solution
forming a protein-NP complex (Figure 1), these protein-NP complexes display oppo-
site cellular binding trends. The cellular binding of cationic NPs is enhanced by the
presence of serum proteins while the binding of anionic NPs is inhibited (Figure 4).
We have determined that these differences in cellular binding are due to the cellular
receptors used by the protein-NP complexes. The protein-NP complex formed from
cationic NPs binds to scavenger receptors on the cell surface (Figure 9A). In com-
parison, the protein-NP complex formed from anionic NPs competes with proteins
present in FBS for cellular binding sites (Figure 9C). It is possible that the use of dif-
ferent cellular receptors is due to adsorption of a low abundance protein not detected
with gel electrophoresis or differences in the conformation of the adsorbed protein on
the NP surface. Differences in protein conformation as a function of charge have been
observed previously for gold surfaces.37 In Chapter 5, we explore the role of protein
conformation on the cellular receptors used by protein-NP complexes.
Our studies focused on polystyrene NPs, modified with chemical groups to con-
trol the effective surface charge. While these NPs provide a good model system,
it is also worth considering how these results may relate to NPs of other compo-
sitions. Binding of serum proteins to NPs appears to be quite general and has
been carefully characterized for aluminum oxide NPs,38 gold NPs and nanorods,18,19
poly(amidoamine) dendrimers,39 and quantum dots.40 The addition of a neutral poly-
mer such as polyethylene glycol can reduce this nonspecific binding, but the complete
inhibition of nonspecific binding remains a challenge.41–43 This suggests that a wide
variety of NPs will be affected by the nonspecific adsorption of serum proteins and
that the interaction of these protein-NP complexes will be highly dependent on the
63
initial NP surface charge. The dependence on scavenger receptors for cellular binding
of the protein-NP complexes formed from the cationic polystyrene NPs is similar to
that observed for 13 nm gold NPs functionalized with DNA or siRNA30 as well as 5
nm gold NPs complexed with albumin.34–36 These results from the literature demon-
strate that scavenger receptors are binding sites for NPs of diverse compositions. In
Chapter 4, our results are extended beyond polystyrene to multiple anionic NPs with
biomedical relevance: quantum dots, gold nanospheres, and low-density lipoprotein
particles.
NP-cell interactions are governed by a number of factors including NP size, compo-
sition, and charge. These interactions are complicated by the presence of extracellular
serum proteins that adsorb on the surface of the NP. We anticipate that a direct com-
parison of the cellular binding of cationic and anionic NPs in the presence of serum
proteins will help reconcile previous results and inform the design of NPs for in vivo
applications.
This chapter was adapted with permission from Reference [21]. Copyright 2012
American Chemical Society.
3.4 References
[1] Anderson, N. L. and Anderson, N. G., “The human plasma proteome: History,
character, and diagnostic prospects.” Mol. Cell. Proteomics, 2002, 1, 845–867.
[2] Pieper, R., Gatlin, C. L., Makusky, A. J., Russo, P. S., Schatz, C. R., Miller, S. S.,
Su, Q., McGrath, A. M., Estock, M. A., Parmar, P. P., Zhao, M., Huang, S. T.,
Zhou, J., Wang, F., Esquer-Blasco, R., Anderson, N. L., Taylor, J., and Steiner,
S., “The human serum proteome: Display of nearly 3700 chromatographically
separated protein spots on two-dimensional electrophoresis gels and identification
of 325 distinct proteins.” Proteomics, 2003, 3, 1345–1364.
[3] Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H.,
Smith, R. D., Springer, D. L., and Pounds, J. G., “Toward a human blood
serum proteome: Analysis by multidimensional separation coupled with mass
spectrometry.” Mol. Cell. Proteomics, 2002, 1, 947–955.
64
[4] Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., and Dawson, K. A.,
“What the cell “sees” in bionanoscience.” J. Am. Chem. Soc., 2010, 132, 5761–
5768.
[5] Lynch, I., Cedervall, T., Lundqvist, M., Cabaleiro-Lago, C., Linse, S., and Daw-
son, K. A., “The nanoparticle-protein complex as a biological entity; A complex
fluids and surface science challenge for the 21st century.” Adv. Colloid Interface
Sci., 2007, 134-135, 167–174.
[6] Treuel, L. and Nienhaus, G. U., “Toward a molecular understanding of
nanoparticle-protein interactions.” Biophys. Rev., 2012, 4, 137–147.
[7] Doorley, G. W. and Payne, C. K., “Cellular binding of nanoparticles in the
presence of serum proteins.” Chem. Commun., 2011, 47, 466–468.
[8] Doorley, G. W. and Payne, C. K., “Nanoparticles act as protein carriers during
cellular internalization.” Chem. Commun., 2012, 48, 2961–2963.
[9] Schnitzer, J. E., “gp60 is an albumin-binding glycoprotein expressed by contin-
uous endothelium involved in albumin transcytosis.” Am. J. Physiol.-Heart C.,
1992, 262, H246–H254.
[10] Schnitzer, J. E., Carley, W. W., and Palade, G. E., “Albumin interacts specif-
ically with a 60-kDa microvascular endothelial glycoprotein.” Proc. Natl. Acad.
Sci., 1988, 85, 6773–6777.
[11] Schnitzer, J. E., Carley, W. W., and Palade, G. E., “Specific albumin binding
to microvascular endothelium in culture.” Am. J. Physiol.-Heart C., 1988, 254,
H425–H437.
[12] Hopkins, C. R. and Trowbridge, I. S., “Internalization and processing of transfer-
rin and the transferrin receptor in human carcinoma A431 cells.” J. Cell. Biol.,
1983, 97, 508–521.
[13] Verma, A. and Stellacci, F., “Effect of surface properties on nanoparticle-cell
interactions.” Small, 2010, 6, 12–21.
[14] Cho, E. C., Xie, J., Wurm, P. A., and Xia, Y., “Understanding the role of surface
charges in cellular adsorption versus internalization by selectively removing gold
nanoparticles on the cell surface with a I2/KI etchant.” Nano Lett., 2009, 9,
1080–1084.
[15] Payne, C. K., Jones, S. A., Chen, C., and Zhuang, X., “Internalization and traf-
ficking of cell surface proteoglycans and proteoglycan-binding ligands.” Traffic,
2007, 8, 389–401.
[16] Lunov, O., Syrovets, T., Loos, C., Beil, J., Delecher, M., Tron, K., Nien-
haus, G. U., Musyanovych, A., Mailaender, V., Landfester, K., and Simmet,
T., “Differential uptake of functionalized polystyrene nanoparticles by human
macrophages and a monocytic cell line.” ACS Nano, 2011, 5, 1657–1669.
65
[17] Gessner, A., Lieske, A., Paulke, B.-R., and Müller, R. H., “Functional groups on
polystyrene model nanoparticles: Influence on protein adsorption.” J. Biomed.
Mater. Res., Part A, 2003, 65A, 319–326.
[18] Brewer, S. H., Glomm, W. R., Johnson, M. C., Knag, M. K., and Franzen,
S., “Probing BSA binding to citrate-coated gold nanoparticles and surfaces.”
Langmuir, 2005, 21, 9303–9307.
[19] Alkilany, A. M., Nagaria, P. K., Hexel, C. R., Shaw, T. J., Murphy, C. J., and
Wyatt, M. D., “Cellular uptake and cytotoxicity of gold nanorods: Molecular
origin of cytotoxicity and surface effects.” Small, 2009, 5, 701–708.
[20] Silin, V., Weetall, H., and Vanderah, D. J., “SPR studies of the nonspecific
adsorption kinetics of human IgG and BSA on gold surfaces modified by self-
assembled monolayers (SAMs).” J. Colloid Interface Sci., 1997, 185, 94–103.
[21] Fleischer, C. C. and Payne, C. K., “Nanoparticle surface charge mediates the
cellular receptors used by protein-nanoparticle complexes.” J. Phys. Chem. B,
2012, 116, 8901–8907.
[22] Freshney, R. I., Culture of Animal Cells. John Wiley and Sons, Inc., Hoboken,
5th edn., 2005.
[23] Pastan, I. and Willingham, M., “Journey to the center of the cell: Role of the
receptosome.” Science, 1981, 214, 504–509.
[24] Szymanski, C. J., Yi, H., Liu, J. T., Wright, E. R., and Payne, C. K., “Imaging
intracellular quantum dots: Fluorescence microscopy and transmission electron
microscopy.” In Rosenthal, S. J. and Wright, D. X., eds., “Nanobiotechnology
Protocols,” Humana Press, 2012.
[25] Callaini, G., Dallai, R., and Riparbelli, M. G., “Microfilament distribution in
cold-treated Drosophila embryos.” Exp. Cell Res., 1991, 194, 316–321.
[26] Watts, R. G. and Howard, T. H., “Evidence for a gelsolin-rich, labile F-actin
pool in human polymorphonuclear leukocytes.” Cell Motil. Cytoskel., 1992, 21,
25–37.
[27] Goldenthal, K. L., Pastan, I., and Willingham, M. C., “Initial steps in receptor-
mediated endocytosis - The influence of temperature on the shape and distri-
bution of plasma-membrane clathrin-coated pits in cultured mammalian-cells.”
Exp. Cell Res., 1984, 152, 558–564.
[28] Harding, C., Heuser, J., and Stahl, P., “Receptor-mediated endocytosis of trans-
ferrin and recycling of the transferrin receptor in rat reticulocytes.” J. Cell Biol.,
1983, 97, 329–339.
66
[29] Guarnieri, D., Guaccio, A., Fusco, S., and Netti, P., “Effect of serum proteins
on polystyrene nanoparticle uptake and intracellular trafficking in endothelial
cells.” J. Nanopart. Res., 2011, 13, 4295–4309.
[30] Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E.,
and Mirkin, C. A., “Scavenger receptors mediate cellular uptake of polyvalent
oligonucleotide-functionalized gold nanoparticles.” Bioconjugate Chem., 2010,
21, 2250–2256.
[31] Harush-Frenkel, O., Debotton, N., Benita, S., and Altschuler, Y., “Targeting of
nanoparticles to the clathrin-mediated endocytic pathway.” Biochem. Biophys.
Res. Commun., 2007, 353, 26–32.
[32] Patil, S., Sandberg, A., Heckert, E., Self, W., and Seal, S., “Protein adsorption
and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.”
Biomaterials, 2007, 28, 4600–4607.
[33] Wilhelm, C., Billotey, C., Roger, J., Pons, J. N., Bacri, J. C., and Gazeau, F.,
“Intracellular uptake of anionic superparamagnetic nanoparticles as a function
of their surface coating.” Biomaterials, 2003, 24, 1001–1011.
[34] Schnitzer, J. E., Sung, A., Horvat, R., and Bravo, J., “Preferential interaction
of albumin-binding proteins, gp30 and gp18, with conformationally modified
albumins. Presence in many cells and tissues with a possible role in catabolism.”
J. Biol. Chem., 1992, 267, 24544–24553.
[35] Schnitzer, J. E. and Bravo, J., “High affinity binding, endocytosis, and degrada-
tion of conformationally modified albumins. Potential role of gp30 and gp18 as
novel scavenger receptors.” J. Biol. Chem., 1993, 268, 7562–7570.
[36] Schnitzer, J. E. and Oh, P., “Albondin-mediated capillary permeability to albu-
min. Differential role of receptors in endothelial transcytosis and endocytosis of
native and modified albumins.” J. Biol. Chem., 1994, 269, 6072–6082.
[37] Nakata, S., Kido, N., Hayashi, M., Hara, M., Sasabe, H., Sugawara, T., and Mat-
suda, T., “Chemisorption of proteins and their thiol derivatives onto gold sur-
faces: Characterization based on electrochemical nonlinearity.” Biophys. Chem.,
1996, 62, 63–72.
[38] Rezwan, K., Meier, L. P., Rezwan, M., Voros, J., Textor, M., and Gauckler,
L. J., “Bovine serum albumin adsorption onto colloidal Al2O3 particles: A new
model based on zeta potential and UV-Vis measurements.” Langmuir, 2004, 20,
10055–10061.
[39] Giri, J., Diallo, M. S., Simpson, A. J., Liu, Y., Goddard, I., William A., Kumar,
R., and Woods, G. C., “Interactions of poly(amidoamine) dendrimers with hu-
man serum albumin: Binding constants and mechanisms.” ACS Nano, 2011, 5,
3456–3468.
67
[40] Hanaki, K.-I., Momo, A., Oku, T., Komoto, A., Maenosono, S., Yamaguchi, Y.,
and Yamamoto, K., “Semiconductor quantum dot/albumin complex is a long-life
and highly photostable endosome marker.” Biochem. Biophys. Res. Commun.,
2003, 302, 496–501.
[41] Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M.,
and Langer, R., “The controlled intravenous delivery of drugs using PEG-coated
sterically stabilized nanospheres.” Adv. Drug Delivery Rev., 1995, 16, 215–233.
[42] Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S.,
Blunk, T., and Müller, R. H., “‘Stealth’ corona-core nanoparticles surface mod-
ified by polyethylene glycol (PEG): Influences of the corona (PEG chain length
and surface density) and of the core composition on phagocytic uptake and
plasma protein adsorption.” Colloids Surf., B, 2000, 18, 301–313.
[43] Walkey, C. D. and Chan, W. C. W., “Understanding and controlling the interac-
tion of nanomaterials with proteins in a physiological environment.” Chem. Soc.
Rev., 2012, 41, 2780–2799.
68
CHAPTER IV
CELLULAR BINDING TRENDS OF BIOMEDICALLY
RELEVANT NANOPARTICLES
4.1 Introduction
The use of nanoparticles (NPs) for biological and medical applications is predicated
on a fundamental understanding of NP interactions with cells. In the course of these
applications, the NP will inevitably encounter extracellular proteins, such as serum
proteins, which readily adsorb onto the NP surface.1,2 The underlying mechanisms
that dictate the interactions of protein-NP complexes with cells is a critical question.
In Chapter 3, using a model system of polystyrene, we observed that the receptors
used by protein-NP complexes are determined by the initial NP surface charge.3
Chapter 4 extends these results to determine if the trends we observed for polystyrene
hold true for NPs with biomedical applications. We examined the cellular binding
of a collection of anionic NPs including quantum dots (QDs), colloidal gold NPs,
and low-density lipoprotein (LDL).4 NPs with different surface modifications and
compositions were used to determine the interactions of a diverse range of NPs with
cells in the presence of serum proteins. We focused solely on anionic NPs for these
studies as commercially available NPs, as well as those used in cellular applications,
are more commonly anionic.
Previously, we determined that anionic, carboxylate-modified polystyrene NPs are
inhibited by the presence of free serum proteins in solution. These free serum proteins
compete with the protein-anionic NP complex for binding sites on the cell surface.
We first measured the cellular binding of carboxylate-modified CdSe/ZnS QDs using
fluorescence microscopy and flow cytometry. Our goal was to determine if NPs with
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the same surface modification, but different composition, follow the same binding
trend as the carboxylate-modified polystyrene NPs. QDs are used as cellular sensors
and probes due to their bright photoluminescence and size-tunable emission proper-
ties.5–7 We then repeated cellular binding studies using citrate-modified gold NPs as
an example of NPs with a different surface modification and composition. Gold NPs
have biomedical applications in drug delivery, cellular and tissue imaging, and cancer
therapy.8,9 Cellular binding was characterized with dark field microscopy and UV-Vis
spectroscopy. As a point of comparison for synthetic QDs and gold NPs, we also mea-
sured the cellular binding of LDL using fluorescence microscopy and flow cytometry.
LDL is a <100 nm particle that serves as a lipid transporter in the blood stream.10
LDL particles are composed of cholesteryl ester, cholesterol, phospholipids, and a
single molecule of apolipoprotein B-100.11 The use of LDL allowed us to determine if
NP surface charge plays a similiar role for biological NPs.
We observed that binding of anionic carboxylate-modified semiconductor QDs,
citrate-modified colloidal gold NPs, and LDL to the cell surface is inhibited by the
presence of serum proteins. These results are identical to the trends observed for
carboxylate-modified polystyrene NPs. As these NPs vary in surface modification
and composition, our results suggest that the initial charge of the NP may be the
determining factor in whether NPs will bind to cells in a physiological environment
where serum proteins are present.
4.2 Results and Discussion
The zeta potential (ZP), hydrodynamic diameter (Dh), and biomedical applications
of the NPs used in cellular binding experiments are presented in Table 3. The hydro-
dynamic diameter of the QDs could not be measured reliably due to strong absorption
and fluorescence by the QDs. From a previous literature report, the hydrodynamic
diameter is ∼10 nm.12 To determine the effect of serum proteins on cellular binding,
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NPs were incubated with cells in minimum essential medium (MEM) without protein
and MEM supplemented with 10% (v/v) fetal bovine serum (FBS). MEM supple-
mented with 10% (v/v) FBS is commonly used as a cell culture medium.13 The
total protein concentration present in a 10% (v/v) FBS solution is approximately 10
mg·mL−1 based on the UV-Vis absorption spectrum. In comparison, physiological
serum protein levels are approximately 70 mg·mL−1.14–16
Table 3: Properties of anionic NPs used in cellular binding experiments
NP Surface Modification ZP (mV) Dh (nm) Applications
QD carboxylate -45.2 ± 1.0 N/Aa Cellular imaging
and sensing,
FRET probes
Gold citrate -17.7 ± 2.9 39.3 ± 2.2 Drug delivery,
in vivo imaging,
photothermal therapy
LDLb N/A -15.8 ± 2.1 68.0 ± 20.6 Lipid transport
aDh ∼10 nm (Chapter 2.1.2). bMeasurements carried out in Minimum Essential
Medium. ZP, zeta potential; Dh, hydrodynamic diameter; QD, quantum dot; FRET,
Förster resonance energy transfer; LDL, low-density lipoprotein.
The mixture of proteins present in FBS represents the complex biological environ-
ment that NPs used for biomedical applications will encounter. As FBS is a mixture
of many different proteins, experiments were repeated using just bovine serum albu-
min, (BSA, 10 mg·mL−1) the protein of greatest abundance in the FBS mixture.14–16
This concentration of BSA is equivalent to the total protein concentration present in
the 10% (v/v) FBS experiments. For all NP binding experiments, cells were kept at 4
◦C to block cellular internalization and only allow NP binding to the cell surface.17–22
4.2.1 Carboxylate-Modified Quantum Dots
We first confirmed that a protein corona formed on the surface of the anionic QDs,
resulting in a protein-QD complex. Previous fluorescence correlation spectroscopy
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experiments have shown that human serum albumin, the main protein present in hu-
man serum,14–16 adsorbs onto the surface of carboxylate-modified QDs.23 To confirm
that a protein corona forms with FBS under the same conditions used in our cellular
binding experiments, we carried out a similar analysis using gel electrophoresis. QDs
(0.8 µM) were incubated for 10 minutes at room temperature in a solution of MEM
supplemented with 10% (v/v) FBS, similar to conditions used in cell culture experi-
ments. Protein-QD complexes were run on a 1% (w/v) agarose gel. As a control, QDs
incubated in both water and MEM in the absence of protein were run on the same
gel. The differing mobilities of QDs in the presence and absence of FBS confirms
that QDs exposed to serum proteins will form a protein-QD complex (Figure 11). In
the absence of protein, QDs show high mobility on the gel (QD + H2O and QD +
MEM). In comparison, the addition of FBS significantly reduces the mobility of the
QDs (QD + FBS). The formation of a protein corona on anionic NPs has also been
observed for polystyrene NPs,3,24 gold nanorods,25 and gold NPs.26 We expect that
the positive residues of the serum proteins interact with the anionic NP surface.27
To study the effect of serum proteins on the cellular binding of QDs, carboxylate-
modified QDs (8 nM) were incubated with BS-C-1 monkey kidney epithelial cells in
MEM, MEM supplemented with 10% (v/v) FBS, and MEM supplemented with 10
mg·mL−1 BSA for 10 minutes at 4 ◦C. The cells were rinsed twice with PBS prior
to imaging to remove QDs that did not bind to the cell surface. In the absence of
serum proteins, anionic QDs readily bind to BS-C-1 cells (Figure 12A). In compari-
son, cellular binding of anionic QDs is blocked by the addition of FBS (Figure 12B).
As with FBS, the presence of BSA blocked the cellular binding of QDs (Figure 12C),
suggesting that the protein-QD complex competes with free BSA in solution for cel-
lular receptors. Flow cytometry, which provides a high-throughput measurement of
cellular fluorescence, was used to quantify the cellular binding of QDs in the presence
of serum proteins (Figure 13). Flow cytometry measurements demonstrate that the
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Figure 11: Formation of a protein corona on carboxylate-modified QDs confirmed
with gel electrophoresis. QDs (green) were incubated in water (QD + H2O), MEM
(QD + MEM), and MEM supplemented with FBS (QD + FBS).
addition of either 10% (v/v) FBS or 10 mg·mL−1 BSA, protein concentrations used
in cell culture, completely inhibits the cellular binding of QDs. Cellular binding is
normalized to 100% QD binding in MEM. The baseline autofluorescence of cells in the
absence of QDs is shown for comparison. Quantitative measurements obtained with
flow cytometry (Figure 13) are in good agreement with the fluorescence microscopy
images (Figure 12).
These results for carboxylate-modified QDs follow the same trend observed for
anionic carboxylate-modified polystyrene NPs with hydrodynamic diameters of 60
nm and 236 nm.3 This suggests that the inhibition of cellular binding of anionic NPs
in the presence of serum proteins is independent of NP composition or diameter.
In addition, previous work with carbon NPs28 and anionic silver nanoclusters29 has
shown decreased cellular uptake of NPs in the presence of serum proteins. This
may indicate a broader trend, although it is important to note that our experiments
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Figure 12: Fluorescence microscopy images of carboxylate-modified QDs (green)
bound to BS-C-1 cells at 4 ◦C. Nuclei are stained with DAPI (blue). QDs were

























Figure 13: Cellular binding of QDs in MEM, MEM supplemented with FBS (FBS),
and MEM supplemented with BSA (BSA) quantified with flow cytometry. Autoflu-
orescence from cells in the absence of QDs (cells only) is shown for comparison.
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measure cellular binding rather than uptake.
4.2.2 Citrate-Modified Gold NPs
As with the QDs, we first confirmed that a protein corona forms on the surface of the
citrate-modified gold NPs. Previous research has shown that a protein corona forms
on the surface of citrate-modified gold NPs after incubation with a mixture of plasma
proteins,30 as well as with BSA alone.27,31 The formation of a protein corona on the
anionic citrate-modified gold NPs was confirmed by incubating gold NPs (1 nM) with
MEM supplemented with 10% (v/v) FBS for 30 minutes at 4 ◦C. The NPs were
then washed with repeated centrifugation and resuspension in H2O. The supernatant
collected after each wash step was run on a polyacrylamide gel (12%). The final
NP pellet was resuspended in a solution containing 6% (w/v) sodium dodecyl sulfate
(SDS), a detergent that will remove adsorbed proteins from the NP surface. The
first two wash steps result in a high concentration of protein in the supernatant (S1,
diluted to 1% (v/v), and S2, diluted to 10% (v/v), Figure 14). After 4 washes, no
protein is detected in the supernatant. The addition of SDS to the gold NP pellet
solubilizes any proteins adsorbed on the NP surface resulting in a band at ∼66 kDa
(NP + SDS). As a control, the addition of water, rather than SDS, does not result
in a protein band (NP + H2O). Based on the molecular weight, it is likely that
BSA (66 kDa) is the main protein adsorbed on the gold NPs. As BSA is the major
component of serum (∼55%),14–16 this is unsurprising. These results are in agreement
with previous reports that BSA adsorbs onto the surface of both citrate-modified26,27
and borohydride-modified gold NPs.32
To image cellular binding, gold NPs (0.34 nM) were incubated with BS-C-1 cells,
grown on glass cover slips, for 30 minutes at 4 ◦C in MEM or MEM supplemented with
10% (v/v) FBS. Cells were washed twice with PBS prior to dark field imaging. Cells
were then fixed to cover slips with 4% (v/v) formaldehyde and sandwiched between
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Figure 14: Formation of a protein corona on the surface of citrate-modified gold NPs
after incubation in MEM supplemented with FBS. NPs were washed via centrifugation
five times and the supernatants (S) were analyzed with gel electrophoresis. NP pellets
were resuspended in either SDS (NP + SDS) or water (NP + H2O). FBS alone is
shown for comparison. Molecular weight (MW) marker shows 225, 150, 100, 75, 50,
35, 25, 15, 10, and 5 kDa.
a second glass cover slip for imaging. Using dark field microscopy, we observed that
gold NPs bind to cells in the absence of serum proteins and that binding is inhibited
in the presence of serum proteins (Figures 15A and 15B). The decreased binding of
citrate-modified gold NPs in the presence of serum proteins is consistent with what
we have observed for carboxylate-modified QDs (Figure 12) and carboxylate-modified
polystyrene NPs.3 Control images acquired in the absence of NPs show the scatter
from cells in MEM (Figure 15C) and MEM supplemented with 10% (v/v) FBS (Figure
15D). We also acquired a dark field image and bright field image of the same cell in
MEM supplemented with 10% (v/v) FBS (Figure 16) to show the localized cellular
regions from which the scattering is observed.
However, substantial gold NP aggregation is observed in medium without serum,
consistent with previous studies.26 This allows for the possibility that aggregated




Figure 15: Dark-field microscopy images of citrate-modified gold NPs (yellow) bound
to BS-C-1 cells at 4 ◦C after incubation in (A) MEM and (B) MEM supplemented
with FBS. Control images show cells in the absence of NPs in (C) MEM and (D)
MEM supplemented with FBS.
A B
Figure 16: Microscopy images of a BS-C-1 cell in MEM supplemented with FBS in
the absence of NPs. (A) Dark field. (B) Bright field.
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To ensure that aggregation was not responsible for the difference in cellular binding,
we compared the cellular binding of protein-gold NP complexes in the presence and
absence of excess FBS. If cellular binding of protein-gold NPs is inhibited by excess
FBS, it suggests that the protein-gold NP complexes compete for the same cellular
receptors as the free serum proteins in solution.
We first characterized the formation of protein-gold NP complexes in solution
using absorption spectroscopy. FBS was titrated into a solution of gold NPs (0.17
nM), and the λmax values were monitored as a function of the protein to NP ratio
(Figure 17A). Changes in the λmax values for the protein-NP complexes relative to
the λmax value of gold NPs in the absence of protein (524 nm) were used with the
Langmuir equation to quantify protein adsorption (Chapter 2.1.1.2). We calculated
a maximum shift in wavelength of ∼5 nm, corresponding to an FBS concentration
of 7.5 µM, or 0.5% (v/v). This concentration is the approximate saturation point of
protein adsorption to 30 nm gold NPs, and was used in binding competition studies
to create a protein-NP complex without excess protein in solution. Interestingly, we
observed a shift in wavelength of 3 nm for the washed NPs, attributed primarily to
loss of the “soft” protein corona during wash steps. From a linear fit of the Langmuir
adsorption isotherm data using a Lineweaver-Burk plot (Figure 17B), we report an
equilibrium association constant of 8.1 x 106 ± 1.4 x 106 M−1. Error bars are present
for all data points but are too small to see on the respective scale.
To measure the cellular binding of non-aggregated protein-gold NP complexes,
we used UV-Vis absorption spectroscopy. Flow cytometry cannot be used to directly
probe binding as gold NPs are not intrinsically fluorescent. Absorption spectra of gold
NP solutions were acquired before and after incubation with cells. The difference in
absorbance values at ∼520 nm was used as a relative measure of gold NPs bound to
the cell surface. Representative UV-Vis difference spectra of gold NPs after incubation
with MEM or MEM supplemented with 10% (v/v) FBS are presented in Figure 18A.
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Figure 17: Langmuir plots of FBS adsorption to gold NPs. (A) Average λmax as a
function of protein coverage. (B) Lineweaver-Burk plot of inverse shift in wavelength
versus inverse FBS concentration.
Protein-gold NP complexes were formed by incubating gold NPs (0.17 nM) in 0.5%
(v/v) FBS for 20 minutes. Complexes were then incubated with cells for 30 minutes.
Relative differences in absorbance after incubation in MEM, MEM supplemented
with 10% (v/v) FBS, or MEM supplemented with 10 mg·mL−1 BSA were normalized
to gold NPs incubated with MEM (Figure 18B). Absorption by MEM incubated
with cells, but without NPs, was negligible. These measurements show that 10%
(v/v) FBS inhibits the cellular binding of gold NPs, similar to the aggregated gold
NPs (Figure 15), carboxylate-modified QDs (Figure 12), and carboxylate-modified
polystyrene NPs,3 although the inhibition is less extensive. BSA alone also inhibits
the cellular binding of the gold NPs. We did not observe a statistically significant
difference between the gold NP binding measured for FBS and BSA. Cellular binding
of the single protein-gold NP complexes was also imaged with dark field microscopy
(Figure 19). While binding of the complexes to cells is observed, quantification is
difficult due to decreased scattering by individual gold NPs.
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Figure 18: Cellular binding of protein-gold NP complexes was measured using the
absorption spectra of gold NPs before and after incubation with the cells. (A) Repre-
sentative difference spectra of gold NPs after incubation with cells in MEM (black),
MEM supplemented with FBS (red), or cells in the absence of NPs (cells only, blue).
(B) Binding of protein-gold NP complexes in MEM, MEM supplemented with FBS
(FBS), and MEM supplemented with BSA (BSA). (Statistical p-values: *p < 0.05;
**p < 0.01; there was no statistically significant difference between FBS and BSA.)
MEM FBSA B BSAC
Figure 19: Dark-field microscopy images of citrate-modified protein-gold NP com-
plexes (yellow) bound to BS-C-1 cells in (A) MEM, (B) MEM supplemented with
FBS, and (C) MEM supplemented with BSA.
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4.2.3 Low-Density Lipoprotein
Low-density lipoprotein (LDL) was used as a representative anionic biological NP.
Unlike QDs and gold NPs, LDL has a dedicated cellular receptor.10 The cellular
binding of LDL was observed by fluorescently labeling LDL with DiD, a red lipophilic
dye. DiD-labeled LDL (100 µg·mL−1) was then incubated with BS-C-1 cells at 4 ◦C
for 20 minutes in MEM and MEM supplemented with 10% (v/v) FBS. In the absence
of serum proteins, significant binding of LDL to cells was observed (Figure 20A).
In the presence of serum proteins, cellular binding of anionic LDL decreases (Figure
20B). These results demonstrate that the cellular binding of anionic LDL follows
the same trends as carboxylate-modified QDs (Figure 12), citrate-modified gold NPs
(Figure 15), and carboxylate-modified polystyrene NPs.3 BSA alone does not inhibit
the cellular binding of LDL (Figure 20C). This suggests that lower abundance proteins
in FBS, most likely lipoproteins, are responsible for inhibiting LDL binding to the cell
surface. These results were quantified with flow cytometry using the same methods
as for the carboxylate-modified QDs (Figure 13). The quantitative flow cytometry
data is in agreement with the qualitative results from fluorescence microscopy (Figure
20). The presence of 10% (v/v) FBS inhibits the binding of LDL relative to MEM
alone (Figure 21, 66% binding), while the addition of 10 mg·mL−1 BSA actually
increases binding (Figure 21, 171% binding). Fluorescence microscopy experiments
were repeated in HeLa cells yielding similar trends (data not shown).
4.3 Conclusions
The common theme that emerges from these experiments is that a broad range of
anionic NPs can form protein-NP complexes and that the cellular binding of these
complexes is inhibited by free serum proteins in solution. The cellular binding of
carboxylate-modified QDs, citrate-modified colloidal gold NPs, and LDL is inhibited
by extracellular serum proteins, similar to previous results for carboxylate-modified
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Figure 20: Fluorescence microscopy images of LDL fluorescently labeled with DiD
(red) bound to BS-C-1 cells at 4 ◦C. Nuclei are stained with DAPI (blue). LDL-DiD
was incubated with cells in (A) MEM, (B) MEM supplemented with FBS, and (C)
MEM supplemented with BSA.




























Figure 21: Cellular binding of LDL particles in MEM, MEM supplemented with
FBS (FBS), and MEM supplemented with BSA (BSA) quantified with flow cytometry.
Autofluorescence from cells in the absence of LDL (cells only) is shown for comparison.
Binding was normalized to 100% in MEM. (Statistical p-values: *p < 0.05; ***p <
0.001)
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polystyrene NPs.3 While this list of NPs is not comprehensive, it demonstrates that
cellular binding trends are consistent for a range of NPs with diverse surface modifi-
cations and compositions. In the case of QDs, the competition of QDs with BSA for
cellular binding sites suggests that the protein-QD complexes utilize BSA receptors
on the cell surface. This may also be true for gold NPs, although the competition is
less extensive. We have explored different methods for studying the cellular binding
of gold NPs, and the relative percent binding does appear to be dependent upon the
method used, i.e. flow cytometry or UV-Vis absorption spectroscopy. For LDL, a
low abundance protein within the FBS mixture is likely responsible for the inhibition
of cellular binding. NPs used in biological and medical applications will encounter
a complex environment of extracellular proteins. Our results show that anionic NPs
will likely have inhibited cellular binding when proteins are present, possibly limit-
ing their efficacy. These results further support the necessity of characterizing NP
interactions with cells in a realistic, biological environment where the presence of
extracellular proteins can greatly alter binding. The following chapter examines the
underlying molecular basis for the differences in the cellular binding of protein-NP
complexes as a function of the structure of adsorbed corona proteins.
This chapter was adapted with permission from Reference [4]. Copyright 2013 The
Royal Society of Chemistry.
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CHAPTER V
ROLE OF CORONA PROTEIN STRUCTURE ON THE
BINDING OF PROTEIN-NANOPARTICLE COMPLEXES
5.1 Introduction
The protein corona controls the cellular interactions of nanoparticles (NPs) by de-
termining the cell surface receptor used by the protein-NP complex.1–4 In Chapter
3, for a model system of polystyrene NPs, we observed that protein-NP complexes
formed with cationic NPs are directed to scavenger receptors while complexes formed
with anionic NPs bind to native protein receptors.1 These results were extended in
Chapter 4 to anionic quantum dots, colloidal gold NPs, and low-density lipoprotein,
a biological NP.2 The cellular binding of each of these biomedically relevant NPs
was inhibited by free serum proteins, observations consistent with experiments using
polystyrene NPs. While we observed in Chapters 3 and 4 that charge is a dominat-
ing factor in the cellular binding of protein-NP complexes, the mechanism for these
differences was unknown. In this chapter, we describe a comprehensive study that
relates the structure of proteins adsorbed on the NP surface to the cellular receptors
used by protein-NP complexes.
To advance the use of NPs for applications in biology and medicine, it is necessary
to understand, on a molecular level, the interaction between adsorbed proteins, NPs,
and cells. The interplay is dynamic as the adsorbed proteins determine the interac-
tions of NPs with cells,3–7 but the NP itself changes the structure and molecular prop-
erties of the proteins in the corona.7–13 In order to unravel the relationship between
the structure of the corona proteins and the cell surface receptors used by the protein-
NP complex, we characterized a model system of anionic, carboxylate-modified and
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cationic, amine-modified polystyrene NPs with similar diameters. Bovine serum al-
bumin (BSA) adsorbs onto the surface of both anionic and cationic NPs resulting in
nearly identical, net anionic, protein-NP complexes. Although the same protein forms
the corona, these protein-NP complexes bind to different cellular receptors. BSA-NP
complexes formed with anionic NPs bind to native protein receptors, while BSA-NP
complexes formed with cationic NPs bind to scavenger receptors. Given that the
same protein results in two different cellular outcomes, this provides an ideal system
to probe the relationship between protein structure and the cell surface receptors.
Using circular dichroism (CD) spectroscopy, we determined that the native structure
of BSA is retained after binding to anionic NPs, while BSA structure is disrupted
on cationic NPs. Isothermal titration calorimetry (ITC) was used to determine equi-
librium association constants, enthalpy of adsorption, and binding stoichiometry of
BSA on both anionic and cationic NPs. Fluorescence quenching experiments support
the trends observed with ITC.
The use of NPs for biological and biomedical applications requires a detailed un-
derstanding of the protein corona.14–16 As all NPs in a physiological environment are
likely to acquire some extent of a protein corona, it is important to understand how
the protein corona will control the interaction of the NP with the cell. This chapter
illustrates the molecular-level relationship between serum protein secondary struc-
ture, NPs, and cell surface receptors, providing a foundation for rational targeting of
diagnostic and therapeutic NPs.
5.2 Results
Experiments were carried out using polystyrene NPs in a range of diameters with
either an anionic, carboxylate-modified or cationic, amine-modified surface. Anionic
and cationic NPs used for comparison were matched as closely as possible in diameter.
We used fluorescent NPs for fluorescence microscopy and flow cytometry experiments.
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Dark, non-fluorescent NPs were used for experiments in which the NP fluorescence
would interfere with the measurement. The hydrodynamic diameter (dh) and zeta
potential (ZP) of all NPs was measured in water (Table 4). The diameter supplied
by the manufacturer, which can differ from the hydrodynamic diameter depending on
characterization method, is used to denote the NP throughout the text. All values
are reported as the mean and standard deviation of at least three experiments.
Table 4: Hydrodynamic diameter (dh) and zeta potential (ZP) of the NPs used in
the course of experiments
NPs dh(nm) ZP (mV)
Fluorescent
93 nm COOH 102.5 ± 1.6 -30.1 ± 5.4
87 nm NH2 152.7 ± 3.2 39.2 ± 3.6
200 nm COOH 236.2 ± 3.3 -31.0 ± 1.6
200 nm NH2 270.1 ± 9.3 19.9 ± 3.4
Dark
60 nm COOH 64.1 ± 1.4 -39.8 ± 3.9
58 nm NH2 63.4 ± 1.2 40.3 ± 4.0
The transmission electron microscopy (TEM) diameter of the fluorescent NPs is
reported in Chapter 3, but was not provided by the manufacturer for the dark NPs.
TEM images of both 60 nm carboxylate-modified and 58 nm amine-modified NPs
were acquired under our experimental conditions with the help of Yusuf Uddin in the
lab of Professor Ingeborg Schmidt-Krey. Images were acquired of unwashed (140 nM,
Figure 22) and washed (14 nM, Figure 23) NPs in Minimum Essential Medium (MEM)
and MEM supplemented with 10 mg·mL−1 BSA. The Feret, or longest, diameter was
measured from the TEM images. The mean TEM diameter of the unwashed NPs
in MEM was 54.6 ± 7.6 for the 60 nm NPs (n = 101 NPs) and 53.6 ± 7.6 for the
58 nm NPs (n = 107 NPs). Histograms show the size distribution of the NPs fit
to a Gaussian distribution (Figure 24). Protein was visible on the unwashed NPs
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after incubation in MEM supplemented with BSA (Figure 22, MEM + BSA). The
protein layer was not evenly distributed over the surface of either NP. We observed
an increase in diameter of ∼7-8 nm on both the 60 nm and 58 nm NPs after BSA
adsorption.
The diameters of washed 60 nm and 58 nm NPs after incubation in MEM were
51.9 ± 5.3 (n = 41 NPs) and 52.7 ± 6.1 (n = 37 NPs), respectively. After washing
the NPs in MEM twice via centrifugation, the diameter was unchanged relative to
the diameter of the unwashed NPs in MEM, demonstrating that the wash steps do
not alter the NP size. Following incubation in MEM supplemented with 10 mg·mL−1
BSA and four wash steps via centrifugation, the diameters of the 60 nm and 58 nm
NPs were 50.2 ± 6.2 nm (n = 84 NPs) and 51.6 ± 6.3 nm (n = 66 NPs), respectively.
It is difficult to observe a protein layer on either NP surface after washing.
















Figure 22: TEM images of unwashed 60 nm carboxylate-modified (60 nm COOH)
and 58 nm amine-modified (58 nm NH2) NPs in MEM and MEM supplemented with
BSA.
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Figure 23: TEM images of washed 60 nm carboxylate-modified (60 nm COOH) and
58 nm amine-modified (58 nm NH2) NPs in MEM and MEM supplemented with BSA.












 60 nm COOH
 58 nm NH2
Figure 24: TEM diameters of 60 nm carboxylate-modified (60 nm COOH) and 58
nm amine-modified (58 nm NH2) NPs. Histograms are fit to a Gaussian distribution.
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5.2.1 Protein Corona Formation
The TEM images demonstrate that protein is present on both anionic and cationic
NPs. However, the TEM images are taken of dried NPs, and NPs used in biological
systems will be in an aqueous solution. To confirm that BSA forms a protein corona
on both anionic and cationic NPs in a representative biological environment, 60 nm
carboxylate-modified (14 nM) and 58 nm amine-modified (0.4 nM) NPs were incu-
bated in MEM supplemented with 10 mg·mL−1 BSA for 10 minutes at 4 ◦C. These
conditions are identical to those used in cellular binding experiments. Free BSA was
removed from solution with four wash steps consisting of centrifugation, removal of
supernatant, and resuspension in water. This method has been shown to remove
unbound protein from solution.1 After the final wash, the pellet was resuspended in a
buffer containing 6% (w/v) sodium dodecyl sulfate (SDS), a detergent that removes
bound BSA,1 and the supernatant was loaded onto a polyacrylamide gel (4-20% gra-
dient). For both anionic and cationic NPs, a protein band is present at ∼66 kDa,
the molecular weight of BSA (Figure 25). NPs resuspended in H2O rather than SDS
leads to the absence of a protein band on the gel (Figure 25). The protein observed
following treatment with SDS is the corona.
Dynamic light scattering was used to monitor the hydrodynamic diameter, poly-
dispersity index (PDI), and zeta potential of the NPs in response to the presence of
BSA (Figure 26). For the 60 nm anionic, carboxylate-modified NPs, increasing con-
centrations of BSA led to an increase in hydrodynamic diameter (64.1 ± 1.4 in water
to 69.8 ± 3.4 in 10 mg·mL−1 BSA) and slight aggregation of the NPs, indicated by
the increasing PDI (Figure 26A). For the 58 nm cationic, amine-modified NPs, the
addition of BSA led to a significantly larger increase in both hydrodynamic diameter
and PDI (Figure 26B). At relatively low protein concentrations (0.01 - 0.1 mg·mL−1
BSA), adsorption of negatively charged proteins cause the initially cationic NPs to
become nearly neutral (Figure 26D). The reduction in surface charge is responsible
92
Figure 25: Gel electrophoresis of 60 nm carboxylate-modified (60 nm COOH) and
58 nm amine-modified (58 nm NH2) NPs following incubation in MEM supplemented
with BSA confirms the presence of a protein corona. SDS was used to remove the
protein corona from the NP surface. Incubation of NPs in H2O, rather than SDS, led
to no visible protein. BSA, in the absence of NPs, is shown for reference. Molecular
weight (MW) marker shows 225, 150, 100, 75, 50, 35, 25, 15, 10, and 5 kDa.
for the observed aggregation of the cationic NPs. These large aggregates are not
observed in cell experiments as they are likely removed, along with unbound NPs,
during the wash steps prior to analysis. The initial zeta potential of the anionic NPs
in water is -39.8 ± 3.9 mV (Figure 26C). In the presence of 10 mg·mL−1 BSA, the zeta
potential increases to -18.5 ± 1.0 mV, similar to the zeta potential of BSA alone (-22
mV). The cationic NPs, with an initial effective surface charge of 40.3 ± 4.0 in water,
become anionic following incubation with BSA, with a final effective surface charge of
-19.0 ± 2.2 in the presence of 10 mg·mL−1 BSA (Figure 26D). The increased diameter
and change in zeta potential support the gel electrophoresis experiments (Figure 25)
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Figure 26: Dynamic light scattering and zeta potential measurements of 60 nm
carboxylate-modified and 58 nm amine-modified NPs in the presence of increasing
concentrations of BSA. Hydrodynamic diameter and polydispersity index of (A) 60
nm carboxylate-modified and (B) 58 nm amine-modified NPs. Zeta potential of (C)
60 nm carboxylate-modified and (D) 58 nm amine-modified NPs.
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Serum, the protein component of whole blood, contains thousands of unique pro-
teins.17–19 Serum albumin is the most abundant protein in the blood stream,17,18
and the bovine and human versions are very similar in structure and function.20,21
We repeated the gel electrophoresis and dynamic light scattering measurements on
protein-NP complexes formed with fetal bovine serum (FBS), the complete mixture of
serum proteins. Gel electrophoresis shows a band at ∼66 kDa (Figure 27) suggesting
that for FBS, the main protein present in the corona of both anionic and cationic NPs
is likely BSA. We observe a similar increase in hydrodynamic diameter for FBS-NP
complexes (Figure 28A), along with the formation of net negatively charged protein-
NP complexes with both anionic and cationic NPs (Figure 28B). NPs incubated in
FBS are larger than NPs incubated in BSA (Figure 26), suggesting that other proteins
and components in FBS contribute to an increased hydrodynamic diameter.
5.2.2 Cellular Binding of BSA-NP Complexes
The cellular binding of anionic and cationic NPs in the presence of BSA was studied
with fluorescence microscopy. Cells are commonly cultured in a buffered solution
such as MEM containing inorganic salts, amino acids, and vitamins. The medium
is supplemented with serum proteins, typically FBS.22 Since our goal was to isolate
molecular level protein-NP-cell interactions, we used the isolated BSA protein for the
majority of experiments.
Fluorescent NPs, either 93 nm anionic, carboxylate-modified or 87 nm cationic,
amine-modified, were incubated with monkey kidney epithelial (BS-C-1) cells in MEM
or in MEM supplemented with 10 mg·mL−1 BSA. This concentration of BSA is ap-
proximately equal to the total protein concentration used in typical cell culture (Chap-
ter 2.3). Cellular binding studies were carried out at 4 ◦C, which allows NP binding
to the cell surface but blocks cellular internalization of the NPs.23–28 For the anionic,
carboxylate-modified NPs, we observed NP binding in MEM (Figure 29A).
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Figure 27: Gel electrophoresis of 60 nm carboxylate-modified (60 nm COOH) and
58 nm amine-modified (58 nm NH2) NPs following incubation in MEM supplemented
with FBS confirms the presence of a protein corona composed primarily of BSA. SDS
was used to remove the protein corona from the NP surface. Incubation of NPs in
H2O, rather than SDS, led to no visible protein. FBS and BSA, in the absence of
NPs, are shown for reference. Molecular weight (MW) marker shows 225, 150, 100,
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60 nm COOH 58 nm NH2
Figure 28: Dynamic light scattering measurements of 60 nm carboxylate-modified
(60 nm COOH) and 58 nm amine-modified (58 nm NH2) NPs in water and in MEM
supplemented with FBS. (A) Hydrodynamic diameter. (B) Zeta potential.
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The addition of BSA significantly inhibited NP binding. Interestingly, we observe
the opposite trend for the cationic, amine-modified NPs. Minimal cellular binding was
observed in MEM while the addition of BSA enhances cationic NP binding (Figure
29B). Similar results were observed for Chinese hamster ovary (CHO) cells (Figure
30). CHO cells are also cultured in a different cell culture medium (Ham’s F-12)
indicating that this trend is not cell type-dependent, nor is it dependent upon the
specific formulation of cell culture medium.
















Figure 29: Fluorescence microscopy images show cellular binding of NPs (green) to
BS-C-1 cells at 4 ◦C in MEM and MEM supplemented with BSA (MEM + BSA).
(A) 93 nm carboxylate-modified NPs. (B) 87 nm amine-modified NPs. Nuclei are
stained with DAPI (blue).
5.2.3 Cellular Receptors used by BSA-NP Complexes
As the cellular binding trends for NPs of similar diameter, but opposite initial surface
charge were different (Figure 29), we sought to identify the cellular receptors used by
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Figure 30: Fluorescence microscopy images show cellular binding of NPs (green) to
CHO cells at 4 ◦C in F-12 and F-12 supplemented with BSA (F-12 + BSA). (A) 93
nm carboxylate-modified NPs. (B) 87 nm amine-modified NPs. Nuclei are stained
with DAPI (blue).
the NPs. Albumin has a dedicated receptor on the cell surface as it is an essential
blood serum protein.29–33 Cellular binding of the anionic, carboxylate-modified NPs
was inhibited by BSA, suggesting that BSA-NP complexes formed from anionic NPs
compete with BSA for binding to the native albumin receptor. To test this hypothe-
sis, we carried out cellular binding competition studies in the presence of increasing
concentrations of BSA. If BSA-NP complexes bind to native albumin receptors, we
expect increasing concentrations of BSA will lead to a decrease in cellular binding
of BSA-NPs. Using flow cytometry as a high-throughput, quantitative measure of
cellular binding, we observe decreased BSA-NP binding in the presence of increasing
concentrations of BSA (Figure 31A). At a BSA concentration of 10 mg·mL−1, sim-
ilar to the concentration used in cell culture, BSA-NP binding was reduced to 32%
relative to 100% in the absence of BSA. This supports the hypothesis that BSA-NPs
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formed from anionic NPs bind to the native albumin receptors on the cell surface.
Since BSA-NP complexes formed from cationic NPs bind to cells in the presence of
excess BSA (Figure 29B), these complexes do not bind to albumin receptors. Previous
studies have shown that some NPs and protein-NP complexes bind to scavenger recep-
tors,1,34–36 specifically scavenger receptors with an affinity for modified albumins.37–39
To determine if the BSA-NPs formed from cationic NPs bind to scavenger receptors,
we carried out competition studies in the presence of both fucoidan (Figure 31B) and
polyinosinic acid (Figure 31C), known competitors for scavenger receptors.38 Com-
petition studies with cationic NPs were carried out in MEM supplemented with 10
mg·mL−1 BSA. Increasing concentrations of fucoidan and polyinosinic acid both led
to decreased cellular binding of the BSA-NP complexes, although fucoidan was a
stronger competitor (11% binding at 2500 µg·mL−1 compared to 25%). As a control,
we measured cellular binding of BSA-NPs formed from cationic NPs in the presence
of polyadenylic acid (Figure 31D). Polyadenylic acid has a similar structure to polyi-
nosinic acid, but is not a competitor for scavenger receptors.40 We did not observe
competition in the presence of polyadenylic acid (polyA, 88% binding compared to a
control normalized to 100%). The contribution from cellular autofluorescence is 9%
(cells only). The error bar is present but too small to see on the respective scale.
5.2.4 Protein Secondary Structure in the Presence of NPs
Our fluorescence microscopy and flow cytometry experiments show that BSA-NP
complexes formed from anionic NPs bind to native protein receptors, while BSA-NP
complexes formed from cationic NPs bind to scavenger receptors (Figures 29 and
31). The same protein binding to different cell surface receptors suggests a structural
difference in BSA following adsorption on the anionic and cationic NPs. To test this
hypothesis, we used circular dichroism (CD) spectroscopy to probe the structure of
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Figure 31: Identification of cell surface receptors using cellular binding competi-
tion assays measured with flow cytometry. (A) Cellular binding of 93 nm anionic,
carboxylate-modified NPs in MEM with increasing concentrations of BSA. (B) Cellu-
lar binding of 87 nm cationic, amine-modified NPs in MEM supplemented with BSA
in the presence of increasing concentrations of fucoidan and (C) polyinosinic acid.
(D) Control experiments show binding of 87 nm amine-modified NPs in the presence
of polyadenylic acid (polyA) and the autofluorescence from cells in the absence of
NPs (cells only).
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BSA, a primarily α-helical protein, the far-UV CD spectrum contains a positive band
at 195 nm and two negative bands at 208 and 222 nm (Figure 32A), in good agreement
with previous CD measurements.41,42 Spectra are in units of mean residue ellipticity
(MRE) and each spectrum is the average of 10 consecutive scans.
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Figure 32: Circular dichroism spectra of BSA in the presence of 60 nm carboxylate-
modified NPs (red), 58 nm amine-modified NPs (blue), and in the absence of NPs
(black). (A) Raw circular dichroism spectra. (B) Circular dichroism difference spectra
were calculated by subtracting the spectrum of BSA from BSA in the presence of 60
nm carboxylate-modified (red) or 58 nm amine-modified NPs (blue). Black dashed
lines correspond to spectral peaks at 195, 208, and 222 nm.
Incubation with 60 nm anionic, carboxylate-modified NPs shows little change
in the CD spectrum (Figure 32A). In comparison, incubation with 58 nm cationic,
amine-modified NPs results in more positive mean residue ellipticity (MRE) values,
indicating a loss in protein secondary structure (Figure 32A). CD difference spectra
were calculated by subtracting the spectrum of BSA alone from the spectrum of BSA
in the presence of NPs (Figure 32B). The difference spectra reveal a larger change
in BSA secondary structure in the presence of cationic, compared to anionic, NPs.
We observe similar results for BSA in the presence of 200 nm NPs (Figure 33). The
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Figure 33: Circular dichroism spectra of BSA in the presence of 200 nm carboxylate-
modified NPs (red), 200 nm amine-modified NPs (blue), and in the absence of NPs
(black). (A) Raw circular dichroism spectra. (B) Circular dichroism difference spectra
were calculated by subtracting the spectrum of BSA from BSA in the presence of 200
nm carboxylate-modified (red) or 200 nm amine-modified NPs (blue). Black dashed
lines correspond to spectral peaks at 195, 208, and 222 nm.
percent α-helicity was calculated using the CD peak at 208 nm (Table 5). The α-
helicity of BSA alone was 65%, consistent with previous reports.43,44 For BSA in
the presence of the 58 nm and 200 nm cationic, amine-modified NPs, a loss in α-
helicity was observed (48% and 37%, respectively), demonstrating that cationic NPs
disrupt the secondary structure of BSA. For BSA in the presence of 60 nm anionic,
carboxylate-modified NPs, a slight increase in α-helicity to 71% was observed. In the
presence of 200 nm carboxylate-modified NPs, there was little change (63%).
Table 5: Percent α-helicity of BSA as a function of NP size and charge
BSA COOH NPs NH2 NPs
60 nm 200 nm 58 nm 200 nm
% α-helix 65 71 63 48 37
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In the case of BSA, we observe that adsorption on cationic NPs disrupts the
secondary structure of the protein while adsorption on anionic NPs does not affect
BSA structure (Figure 32). To determine if this trend was general, we examined
the structure of transferrin, an iron-transporting serum protein,28,45 in the presence
of 60 nm carboxylate-modified and 58 nm amine-modified NPs (Figure 34). For
transferrin, a loss in secondary structure was observed in the presence of the 60 nm
anionic, carboxylate-modified NPs, but not the 58 nm cationic, amine-modified NPs.
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Figure 34: Circular dichroism spectra of transferrin (Tf) in the presence of 60 nm
carboxylate-modified NPs (red), 58 nm amine-modified NPs (blue), and in the absence
of NPs (black). Inset shows full-scale spectra.
5.2.5 Thermodynamic Parameters of BSA Adsorption on NPs using Isother-
mal Titration Calorimetry
The equilibrium association constant, enthalpy, and binding stoichiometry of BSA
adsorbed on 60 nm anionic, carboxylate-modified NPs and 58 nm cationic, amine-
modified NPs was determined using isothermal titration calorimetry (ITC) (Figure
35). The NP concentration was optimized for each individual NP solution so that
BSA saturation on the NP surface was achieved. The heat of dilution of BSA into
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buffer was subtracted from the titration curve of BSA into the NP solution (Figure
36). As the plots of differential power in Figure 35 have been corrected for BSA
dilution, the raw differential power plots were also plotted using the TA Instruments
software, NanoAnalyze (Figure 37, top plots). The titration curves are more evident
in the bottom plots of integrated heat values, as the enthalpy of BSA dilution has
been subtracted from the titration.
An independent site model was used to fit the integrated titration curves and
extract thermodynamic parameters (Table 6).46 The association constant was nearly
an order of magnitude higher for BSA adsorbed on anionic NPs with Ka values of 2.4
± 0.9 x 105 M−1 and 4.0 ± 0.5 x 104 M−1 for 60 nm anionic, carboxylate-modified and
58 nm cationic, amine-modified NPs, respectively. The enthalpy of BSA binding to
the 60 nm carboxylate-modified (-1.4 ± 0.4 x 104 kJ·mol−1) and 58 nm amine-modified
(-1.4 ± 0.7 x 104 kJ·mol−1) NPs was almost identical. A significantly greater number
of BSA molecules adsorbed onto the surface of the 60 nm NPs (871 ± 21 proteins per
NP) compared to the 58 nm NPs (27 ± 8 proteins per NP). The percent coverage,
relative to a monolayer coverage of 100%, was calculated assuming BSA binds end-on,
maximizing the number of BSA molecules in a monolayer.47,48 The coverage of BSA
on the 60 nm carboxylate-modified NPs was 230 ± 6%, compared with significantly
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Figure 35: Isothermal titration calorimetry plots of differential power throughout
the titration (top) and the integrated heat of injection as a function of the mole ratio
of BSA adsorbed onto NPs (bottom). (A) BSA titrated into a solution of 60 nm
carboxylate-modified NPs. (B) BSA titrated into a solution of 58 nm amine-modified
NPs.
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Figure 36: Isothermal titration calorimetry plot of BSA titrated into buffer in the
absence of NPs. Peaks were subtracted injection-by-injection from the titration of
BSA into a solution containing NPs.
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Figure 37: Isothermal titration calorimetry plots of differential power throughout
the titration (top) and the integrated heat of injection as a function of the mole ratio
of BSA adsorbed onto NPs (bottom) displayed using the TA Instruments software,
NanoAnalyze. (A) BSA titrated into a solution of 60 nm carboxylate-modified NPs.
(B) BSA titrated into a solution of 58 nm amine-modified NPs. The titration curve
is more evident in the bottom plot of integrated heat values as the enthalpy of BSA
dilution into buffer has been subtracted from the titration of BSA into NPs.
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60 nm COOH 2.4 ± 0.9 -1.4 ± 0.4 871 ± 21 230 ± 6%
58 nm NH2 0.40 ± 0.05 -1.4 ± 0.7 27 ± 8 8 ± 2%
5.2.6 Fluorescence Spectroscopy of BSA in the Presence of NPs
Fluorescence spectroscopy was used as a complementary technique to measure equi-
librium association constants by monitoring the quenching of tryptophan at ∼340 nm
(Figure 38A).49–51 The spectra were corrected by subtracting the contribution from
NPs alone and buffer. The intensity at λmax was calculated for each experiment. The
ratio of fluorescence intensities in the absence and presence of NPs was plotted versus
NP concentration in a Stern-Volmer plot (Figure 38B). As the plots were non-linear
at higher NP concentrations, the first four points were used for a linear fit to extract
an effective Stern-Volmer equilibrium constant (KSV , Chapter 2.7.2). The effective
KSV is approximately equal to the effective Ka.
51 For BSA in the presence of 60 nm
carboxylate-modified NPs, the effective Ka is 1.8 ± 0.1 x 109 M−1, compared to the
58 nm amine-modified NPs with an effective Ka of 7.7 ± 0.1 x 108 M−1. These values
are several orders of magnitude higher than the Ka values calculated from ITC data
(Table 6).
The normalized fluorescence spectra of BSA in the presence of increasing NP
concentrations used to generate the Stern-Volmer plot are shown in Figure 39. The
maximum fluorescence emission wavelengths are reported in Table 7. The peak wave-
length of BSA in the presence of 58 nm amine-modified NPs was slightly more blue
shifted (329 ± 3 nm) at the highest NP concentration of 0.53 nM compared to the 60
nm carboxylate-modified NPs (332 ± 0 nm) relative to BSA in the absence of NPs
(339 ± 0.6 nm).
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Figure 38: Fluorescence quenching of BSA in the presence of NPs. (A) Raw fluo-
rescence spectra of BSA in the presence of 60 nm carboxylate-modified NPs (red),
58 nm amine-modified NPs (blue), and in the absence of NPs (black). The black
dashed line at 340 nm corresponds to the emission from tryptophan residues in BSA.
(B) Stern-Volmer plot of BSA quenching in the presence of increasing concentrations
of NPs. The contribution from NPs alone and buffer were subtracted from the raw
spectra. The solid lines correspond to an exponential fit of the raw data. Dashed lines
are the initial slope used to calculate an effective equilibrium constant (Equation 3).

































































Figure 39: Normalized fluorescence spectra of BSA in the presence of increasing
concentrations of (A) 60 nm carboxylate-modified NPs and (B) 58 nm amine-modified
NPs.
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Table 7: Maximum fluorescence emission wavelengths for BSA in the presence of
carboxylate-modified (60 nm COOH) and amine-modified (58 nm NH2) NPs
NP 0 nM 0.067 nM 0.13 nM 0.27 nM 0.53 nM
60 nm COOH 339 ± 0.6 338 ± 0.6 338 ± 1 335 ± 2 332 ± 0
58 nm NH2 339 ± 0.6 339 ± 2 336 ± 1 335 ± 2 329 ± 3
5.3 Discussion
5.3.1 Formation of BSA-NP complexes
NPs used in any biological application are exposed to a complex mixture of extracel-
lular proteins that form a protein corona on the NP surface.3,17–19,47,52–57 Although
polyethylene glycol can reduce corona formation, complete inhibition remains a chal-
lenge.58–62 We have characterized the changes in protein secondary structure that
result from adsorption to the NP surface and then relate these structural changes to
the cell surface receptor used by the protein-NP complex. BSA adsorbs onto both
anionic and cationic NPs to form a BSA-NP complex (Figures 25 and 26). Adsorp-
tion of proteins onto both anionic and cationic NPs has been observed previously by
our group and others.1–3,5,6,47,55–57,63 Our results confirm that a BSA-NP complex is
formed under the conditions used in subsequent experiments. Incubating NPs in the
complete mixture of serum proteins present in FBS, rather than isolated BSA, shows
that BSA is the only protein detected in the corona (Figure 27), confirming that BSA
is a good representative serum protein. Similar results were obtained for gold NPs
between 10 and 200 nm.2,64,65
We also characterized the 60 nm carboxylate-modified and 58 nm amine-modified
NPs using TEM. While TEM is not a solution-based measurement, the TEM di-
ameter provides detailed information about the size distribution of NPs present in
experiments (Figure 24). The Feret, or longest, diameter was measured from the
TEM images. As the calculated circularity was approximately 1 for both NPs, the
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Feret diameter is a good approximation of the NP diameter.
The thickness of the protein layer was measured from the TEM images of un-
washed NPs incubated in MEM supplemented with 10 mg·mL−1 BSA (Figure 22).
The increase in diameter of the NPs in the presence of BSA was ∼7-8 nm. This is
consistent with previous reports that a 7 nm increase in diameter was observed on
gold NPs coated with BSA.66 We also observe a high number of protein aggregates
in the images of 58 nm amine-modified NPs in the presence of BSA (Figure 22B).
The protein aggregates appear as dark patches in the background, suggesting that
the presence of amine-modified NPs can cause a structural change to proteins, even
proteins not directly adsorbed to the NP surface.
While BSA has an isoelectric point of 4.7 and is net negatively charged at physio-
logical pH,67 it contains both positive and negative residues.68,69 Adsorption of BSA
onto the surface of anionic, carboxylate-modified NPs results in a slight increase in NP
diameter and effective surface charge (Figures 26A and 26C), although the protein-
NP complexes remain negatively charged (-18.5 ± 1.0 mV). At higher concentrations
of BSA, some aggregation of NPs is observed by an increase in PDI (Figure 26A).
The aggregates were removed during wash steps prior to cellular binding and com-
petition assays. Cationic, amine-modified NPs are more sensitive to the addition
of BSA. Low concentrations (0.01-0.1 mg·mL−1) of BSA result in a nearly neutral
NP that readily aggregates in solution (Figures 26B and 26D). At the BSA concen-
trations used in these experiments (10 mg·mL−1), the initially cationic NPs become
negatively charged (-19.0 ± 2.2 mV). In the presence of 10 mg·mL−1 BSA, both an-
ionic and cationic NPs are net anionic, forming BSA-NP complexes that are nearly
identical based on dynamic light scattering and zeta potential measurements (Figure
26).
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5.3.2 Cellular Binding Trends of BSA-NP Complexes
While BSA-NP complexes formed with anionic and cationic NPs have identical corona
compositions and surface charges (-18.5 mV and -19.0 mV, respectively), the cellu-
lar binding trends are drastically different. Cellular binding of BSA-NP complexes
formed with anionic NPs is inhibited by the presence of excess BSA (Figure 29A). In
comparison, the cellular binding of complexes formed with cationic NPs is strongly
enhanced by BSA (Figure 29B). This difference in binding is independent of cell type
as similar results were obtained for CHO cells (Figure 30). The differences in cellular
binding suggest that the BSA-NP complexes formed with anionic and cationic NPs
bind to different receptors. In a series of cellular binding competition studies, we
observe that protein-NP complexes formed from anionic NPs bind to native albu-
min receptors, as these complexes are inhibited by increasing concentrations of BSA
(Figure 31A). This suggests that BSA on the NP surface is recognized by the native
receptor. In comparison, BSA-NP complexes formed with initially cationic NPs bind
to scavenger receptors (Figures 31B and 31C).
Scavenger receptors are a broad class of receptors that bind modified low-density
lipoproteins, modified proteins, polysaccharides, and polyribonucleotides.37–39,70,71
Several others have reported that scavenger receptors can bind NPs and protein-
NP complexes.34,35,37–39 Schnitzer et al. determined that chemically or structurally
modified albumins, including albumin-gold NP complexes, bind preferentially to the
glycoprotein (gp) scavenger receptors gp30 and gp18 rather than the general class
of modified protein receptors.37–39 Mirkin et al. have observed that oligonucleotide-
conjugated gold NPs bind to scavenger receptors.34,35 Previous results using a com-
plete mixture of FBS showed identical binding trends,1 demonstrating that this result
is not specific to isolated BSA.
Interestingly, for the BSA-NP complexes formed from cationic NPs, we observed
that fucoidan is a much stronger competitor than polyinosinic acid (Figures 31B and
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31C). At the highest competitor concentration (2500 µg·mL−1), BSA-NP binding was
11% in the presence of fucoidan, compared to 25% in the presence of polyinosinic acid.
It is important to note that the concentration of polyinosinic acid used in these stud-
ies was relatively high compared to previously reported concentrations for cellular
binding competition,1,35 further confirming that polyinosinic acid is a less efficient
competitor. Polyinosinic acid is a competitor for both gp30 and gp18,37–39 as well
as the general class of modified protein receptors.72 In comparison, fucoidan is only
a competitor for the gp30 and gp18 receptors.37–39 The same concentration of polyi-
nosinic acid is then less efficient at competing for modified albumin receptor sites as
some of the molecules will also bind to general modified protein receptors. We propose
that BSA-NP complexes formed from cationic NPs only bind to the receptors for mod-
ified albumins, gp30 and gp18, and not the general receptors for modified proteins. As
fucoidan is only blocking the gp30 and gp18 receptors, it is a more effective competi-
tor for the BSA-NP complexes. For comparison, we observed that polyinosinic acid
competes more with protein-NP complexes formed with a mixture of serum proteins
compared with BSA-NP complexes,1 presumably because the mixture of serum pro-
teins can bind to both types of modified protein receptors. Although further studies
are required to determine the exact binding mechanism to specific scavenger recep-
tors, these results highlight subtle differences in molecular-level interactions of NPs
with cellular receptors.
5.3.3 Structure of Corona Proteins
The opposite binding trends observed for BSA-NP complexes formed from anionic and
cationic NPs provided an optimal model system to study the effect of protein structure
on the cellular receptors used by BSA-NP complexes. We hypothesized that BSA
adsorbed on anionic NPs retained its native structure allowing the BSA-NP complexes
to be recognized by the native albumin receptor. In comparison, we predicted that
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BSA adsorbed on cationic NPs was disrupted, likely partially denatured, such that
it is no longer recognizable by the native protein receptor and is instead redirected
to a scavenger receptor. CD spectra of BSA in the presence of 60 nm anionic NPs
show that the secondary structure of BSA is retained (Figure 32). In comparison,
there is a loss in α-helicity for BSA in the presence of 58 nm cationic NPs (65% to
48%, Table 5). Similar results were obtained for BSA in the presence of 200 nm NPs
(Figure 33). The greater loss in α-helicity on the 200 nm NPs is attributed to more
BSA adsorption on the larger NPs, as the spectra include contributions from both
free BSA in solution and BSA in direct contact with the NP surface.
While the decrease in α-helicity appears modest, boiled BSA has a similar percent-
age of α-helices as BSA on carboxylate-modified NPs (71% α-helix, data not shown).
This indicates both a significant change in α-helicity for BSA on cationic NPs, as well
as a difference in secondary structure for BSA disrupted as a result of boiling versus
bound to a cationic NP surface. Changes in protein secondary structure are gener-
ally accompanied by the exposure of new peptide sequences in the protein. However,
changes in secondary structure precede epitope exposure and higher order structural
changes, and ultimately determine the cellular receptors used by the protein.
Based on these results, it is tempting to generalize: proteins maintain their struc-
ture following adsorption onto an anionic NP, while cationic NPs will disrupt protein
structure. However, individual proteins will interact differently with the NP surface
making it difficult to predict structural changes. As an example, we also examined
the secondary structure of transferrin, an iron-transporting serum protein.28,45 Using
CD spectroscopy, we found that transferrin was denatured following incubation with
anionic, rather than cationic NPs (Figure 34). A possible reason for this difference is
illustrated by electrostatic site maps (Figure 40). Like BSA (Figure 40A), transferrin
has regions of both positive and negative charge. However many regions of the trans-
ferrin surface are nearly neutral suggesting that other interactions (i.e. hydrophobic)
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may dominate (Figure 40B). Transferrin contains a mixture of both α-helices and
β-sheets, compared to BSA which only contains α-helices. Differences in secondary
structure composition also contribute to the overall interaction with charged NPs.
The CD spectroscopy experiments demonstrate that changes in protein secondary
structure are protein-specific and will likely need to determined experimentally for
each protein of interest.
A B
Figure 40: Electrostatic surface maps created with eF-surf. (A) BSA. (B) Trans-
ferrin. Red corresponds to negative (-0.1 V), white corresponds to neutral, and blue
corresponds to positive (+0.1 V) electrostatic potential.
5.3.4 Thermodynamics of the Protein Corona
A change in protein secondary structure should be associated with changes in ad-
sorption on the NP surface. Using ITC (Figure 35), we observe that fewer proteins
adsorbed on the cationic, amine-modified NPs (27 ± 8 proteins per NP, compared
to 871 ± 21 proteins per NP for anionic NPs). The coverage of BSA on the cationic
NPs is likely an underestimate due to dimerization of these NPs during the titration.
Similar results were obtained for sulfate-modified polystyrene NPs, which showed less
than monolayer adsorption of BSA and disruption of BSA secondary structure.44
The lower binding stoichiometry is likely due to the loss of BSA secondary structure.
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When spread out on the NP surface, fewer BSA molecules can access the surface with-
out an energy cost. This hypothesis is reinforced by the thermodynamic data (Table
6). The enthalpy of BSA binding to anionic and cationic NPs is identical (-1.4 ± 0.4
x 104 and -1.4 ± 0.7 x 104 kJ·mol−1, respectively) which is surprising given that the
maximum BSA adsorption to the surface of the 60 nm NPs is approximately 30-fold
greater than on the 58 nm NPs. However, the association of BSA is much stronger on
the anionic NP surface (2.4 ± 0.9 x 105 compared with 4.0 ± 0.5 x 104 M−1), which we
attribute to more energetically favorable packing of native BSA and possibly some
degree of binding cooperativity. Previous ITC experiments have examined protein
adsorption on NPs as a function of protein species and hydrophobicity.54,63,73,74 Most
similar to our measurements are experiments carried out by Baier et al. examining
BSA adsorption onto ∼200 nm polystyrene NPs.63 Equilibrium association constants
and enthalpies are similar, considering the variability in ITC measurements. However,
27% protein coverage was observed for carboxylate-modified NPs and 63% coverage
of amine-modified NPs,63 compared to 230% and 8%, respectively, in our experiments
(Table 6). This difference could be due to multiple factors, namely differences in NP
diameter (200 nm versus 60 nm), pH, buffer, and surface modification. One reason
for the difference in coverage as a function of NP surface charge is attributed to the
magnitude of the surface charge. Baier et al. used cationic NPs with an initial zeta
potential of +7 mV, compared to our experiments where cationic NPs had a zeta
potential of +40 mV. As the number of charged surface groups on the NP has a
large effect on electrostatic and hydrophobic interactions with proteins, this is one
possibility for the observed difference in surface coverage. However, these prior ex-
periments used BSA titrated into water as a control whereas we used BSA titrated
into buffer. It is unclear what buffer was used for ITC experiments, and the enthalpy
of ionization of the buffer greatly influences thermodynamic parameters. The differ-
ences between our results and previous studies with polystyrene NPs highlights the
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difficulty of comparing ITC results under even slightly different conditions.
As a complementary method to ITC, fluorescence quenching was used to mea-
sure equilibrium association constants (Figure 38). The non-linear Stern-Volmer plot
(Figure 38B) is indicative of a selective quenching mechanism.50,51 At low NP concen-
trations, readily accessible tryptophan residues on BSA are quenched uniformly. In
the presence of higher NP concentrations, the NP has limited access to BSA residues
that can be quenched. Lower accessibility of the NP leads to selective quenching. The
stronger association of BSA on 60 nm anionic compared to 58 nm cationic NPs was
observed in both the ITC and fluorescence spectroscopy data, although the absolute
values differ by several orders of magnitude (e.g. Ka = 2.4 ± 0.9 x 105 M−1 with ITC
versus 1.8 ± 0.1 x 109 M−1 from fluorescence spectroscopy for 60 nm anionic NPs).
Thermodynamic parameters are highly sensitive to experimental conditions and, for
our experiments, the buffers required to optimize ITC and fluorescence spectroscopy
experiments were not identical. While ITC provides a better quantitative measure of
the association constant as it is a direct, label-free measurement,75 the use of multiple
methods to confirm thermodynamic parameters is essential.59 Fluorescence quench-
ing has been used previously to study the adsorption of BSA on gold,59,76 silver,77
and silver-titanium dioxide NPs.78 Equilibrium binding constants of 1010 to 1011 were
reported for gold, 105 for silver-titanium dioxide, and 1010 to 1016 M−1 for silver
depending on temperature. The high variability in reported equilibrium binding con-
stants could be due to the fluorescence spectroscopy method itself, in addition to the
fact that binding strength is highly sensitive to NP material, size, and surface modifi-
cation. The exact mechanism by which the BSA fluorescence is quenched is unknown.
Possible mechanisms include energy transfer from the protein to the high energy NP
surface, absorption of BSA emission by the polystyrene, quenching of newly exposed
residues by water molecules, or anisotropic fluorescence as a result of limited BSA
rotation when bound to the NP.
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In addition to the fluorescence quenching dynamics, the peak wavelength at the
fluorescence maximum are also sensitive to the local environment. BSA contains
phenylalanine, tyrosine, and tryptophan residues, all of which can contribute to the
intrinsic protein fluorescence.79,80 However, the quantum yield of phenylalanine is
lower than both tyrosine and tryptophan, and as such contributes minimally to the
fluorescence spectrum. All of these residues are subject to quenching by other residues
and from exposure to the solvent, and BSA fluorescence is primarily due to the
tryptophan residue at position 212.79,81 This residue is located in a hydrophobic region
of sub-domain IIA. In our experiments, we observe a blue shift in BSA fluorescence in
the presence of both 60 nm anionic and 58 nm cationic NPs. We see a slightly larger
wavelength shift for BSA in the presence of 0.53 nM 58 nm amine-modified NPs (329 ±
3 nm) compared with 0.53 nM 60 nm carboxylate-modified NPs (332 ± 0 nm) (Table
7). A blue-shift in fluorescence is indicative of a transition to a more hydrophobic
local environment.79 This suggests that the interaction of 58 nm amine-modified NPs
with BSA creates a change in structure that exposes the tryptophan residue to either
the hydrophobic surface of the NP itself or a hydrophobic residue in close proximity
within the protein. While the changes in fluorescence peak wavelength are marginal,
this data supports the CD data which showed a larger change in BSA structure on
the surface of 58 nm amine-modified NPs compared with 60 nm carboxylate-modified
NPs.
5.4 Conclusions
Using a model system, we demonstrate a molecular link between the structure of the
proteins that comprise the corona and the cellular receptors used by the protein-NP
complex. We observed that changes in protein structure upon adsorption to NPs
determine the cell surface receptor used by the protein-NP complex. In the case of
BSA, protein secondary structure is retained upon adsorption to anionic NPs allowing
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the BSA-NP complex to bind to native albumin receptors. BSA is denatured following
adsorption to cationic NPs, directing the BSA-NP complexes to bind to scavenger
receptors. These results have important implications for the in vivo targeted delivery
of NPs. Beyond merely confirming the presence of a protein corona, it is also critical
to characterize the structure of the corona proteins. Composition, dynamics, and
protein structure of the corona will all affect cellular and physiological outcomes. We
anticipate these results will be useful in the design of NPs for use in physiological
environments, ultimately paving the way for targeted, personalized nanomedicine.
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CHAPTER VI
CONCLUSIONS AND FUTURE WORK
6.1 Conclusions and Outlook
Characterizing fundamental interactions of NPs with cells is essential for the tran-
sition of NPs out of in vitro systems and into clinical applications. NP properties
such as size, composition, and surface charge, combined with the extracellular pro-
teins adsorbed to the NP surface all influence cellular interactions of the protein-NP
complex. We observed the formation of a protein corona on the surface of a diverse
range of NPs. Our studies have shown that initial NP surface charge dominates the
cellular binding of NPs in the presence of serum proteins and determines the cellu-
lar receptors used for binding. These cellular binding trends are attributed to the
molecular properties and structure of adsorbed proteins (Figure 41).
We focused primarily on a model system consisting of polystyrene NPs and the
serum albumin protein. We further demonstrated that the effect of NP surface charge
on cellular binding is a general trend. Consistent results were also observed for
biomedically relevant NPs including quantum dots, colloidal gold NPs, and low-
density lipoprotein. While we observed that initial NP surface charge modulates
protein secondary structure for our model system, structure is dependent upon both
the type of protein as well as the NP properties and will have to be characterized
for each system of interest. The complexity in protein structural studies lies in the
diverse number of proteins that can adsorb to the surface of individual NPs. This is
further complicated by the dynamic composition of the corona, emphasizing the im-
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Figure 41: Cellular binding of protein-NP complexes. A corona composed primarily
of BSA adsorbs onto the surface of both anionic and cationic NPs. The molecular
properties of BSA differ based on the initial NP charge and subsequently determine
the cellular receptors used for binding.
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The presence of a protein corona will ultimately influence NP distribution, accu-
mulation, and eventual clearance. NP clearance mechanisms from cells, tissues, and
organs are not well understood and are further challenged by the lack of a good model
system. Cellular experiments and mouse models work well for fundamental and proof
of concept studies, but the dynamics of corona formation, circulation, and retention
times will differ in humans.1 Extrapolation from the cellular environment to realistic
observations in clinical trials remains a significant hurdle.
This dissertation has focused on cellular binding as this is the first step in the
course of most biomedical applications of NPs. However, the protein corona will
also influence the internalization and transport pathways of the NP. Directing cellu-
lar binding, understanding mechanisms of cellular internalization, and characterizing
transport dynamics of protein-NP complexes are future avenues for the research pre-
sented in this dissertation.
6.2 Future work
While we have characterized the effect of NP charge and protein structure on the cel-
lular binding of protein-NP complexes, these fundamental studies must be expanded
to understand the complete mechanistic details of NP interactions with cells. Two
primary areas of future research are included here with accompanying preliminary
data.
6.2.1 Cellular Binding
We have observed that initial NP surface charge determines both the structure of
adsorbed proteins along with the cellular receptor used by the protein-NP complex.
Specifically, we observed that the protein structure of BSA is retained on anionic NPs,
allowing complexes formed with anionic NPs to bind to native albumin receptors. To
further verify this result, we have attempted to steer anionic NPs away from native
BSA receptors by incubating the anionic NPs with denatured proteins prior to cellular
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binding studies. We expect that the protein-NP complex formed with anionic NPs
will no longer be recognized by the native BSA receptor, which is the trend we
observed for cationic NPs. However, these steering experiments have proven to be
extremely challenging, as we have used BSA that was boiled, modified with H2CO,
and denatured with guanidine salts, all to no avail. In all cases, anionic NPs were
still blocked by free BSA indicating that the protein-NP complex can access and be
recognized by native BSA receptors.
However, we observed that using BSA labeled with AlexaFluor647 (AF647) leads
to mixed competition (Figure 42). Incubation with MEM supplemented with 10
mg·mL−1 BSA leads to a decrease in binding (68% relative to 100% cellular binding
in MEM). The presence of 250 µg·mL−1 polyinosinic acid also leads to a decrease in
binding (63%), and the presence of both BSA and polyinosinic acid leads to nearly
complete inhibition (48%) relative to the cell background. The autofluorescence from
cells alone is 43%. These results demonstrate that fluorescently labeled BSA com-
petes both with free BSA as well as a molecule that binds to scavenger receptors.
Fluorescently labeling BSA likely leads to a distribution of protein structures (and
exposed epitopes) that allows a subset to bind to native receptors and another subset
to bind to scavenger receptors. We anticipate a similar effect is occuring after adsorp-
tion of BSA to the NP surface. We also expect that the disrupted structure of BSA
on cationic NPs is not the same as BSA denatured by other methods, and molecular
differences in protein structure are responsible for the challenges in steering anionic
NPs away from native protein receptors. Future experiments will need to determine
the degree and type of denaturation that causes BSA to no longer be recognized by
the native receptor. An additional control would be to find or produce a cell line that
does not have an albumin receptor and repeat binding experiments with anionic NPs
coated with albumin. We would expect that the albumin-NP complex would either

































Figure 42: Cellular binding competition studies of BSA-AF647 in MEM, MEM
supplemented with BSA (BSA), MEM supplemented with polyinosinic acid (polyI),
and MEM supplemented with both BSA and polyinosinic acid (BSA + polyI). Control
experiment shows autofluorescence from cells in the absence of BSA-AF647 (cells
only).
6.2.2 Cellular Internalization and Transport
While our experiments have focused primarily on cellular binding, the effect of the
protein corona on NP cellular internalization is also key to understanding NP efficacy.
Previous research in our group demonstrated that protein stays bound to the NP as
protein-NP complexes bind to and cross the plasma membrane.2,3 This suggests that
NP internalization and transport is at least partially dependent upon the protein
adsorbed onto the surface.
In order to probe the differences in intracellular transport of free BSA and BSA
bound to a NP, BS-C-1 cells were incubated with either BSA-NP complexes or BSA-
AF647 at 37 ◦C. Incubation at 37 ◦C allows both cellular binding and internalization
to occur. Complexes were formed with 87 nm amine-modified, green fluorescent NPs
(34 pM) incubated with 6 µM BSA for 20 minutes before adding to cells. The lyso-
some was used as a terminal vesicle for endocytic transport, and the fluoresently
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labeled lysosome-associated membrane protein-1 (LAMP1) was used to image lyso-
somes. For studies with BSA-AF647, BS-C-1 cells stably expressing LAMP1 labeled
with enhanced yellow fluorescent protein (EYFP) were used. For BSA-NP internal-
ization studies, the LAMP1 protein was immunofluorescently labeled with red Cy5
(Chapter 2.4.2).
The transport of BSA-NP complexes and BSA-AF647 was visualized as a function
of time using confocal fluorescence microscopy, and colocalization with lysosomes via
the LAMP1 protein was calculated (Figure 43). After 10 minutes, 10 ± 9% of BSA-NP
complexes were found in lysosomes compared to 51 ± 21% of BSA-AF647, suggesting
a slightly slower accumulation of BSA-NP complexes into lysosomal vesicles. The
accumulation is dependent on a number of factors including, but not limited to the
amount of NPs or proteins that can be contained in a single vesicle, rate of transport to
the lysosome, as well as the limits of visualization inherent to fluorescence microscopy.
We expect that some of the observed difference is due to the fact that BSA-AF647
cannot be visualized below an accumulation threshold. After 18 hours, the majority
of BSA-NP complexes and BSA-AF647 are found in lysosomes (78 ± 20% and 90
± 7%, respectively). Overlay images demonstrate colocalization after incubation for
18 hours (Figures 43A and 43B). The colocalization signal appears yellow in the
images. Individual images used to form overlays are shown in Figure 44. While
this strongly suggests that both BSA and BSA-NP complexes are transported via
the endocytic pathway, the exact internalization mechanism is unknown. For anionic
NPs, the process should be similar to that of the BSA protein, as anionic NPs bind to
native albumin receptors on the cell surface. Future work should focus on determining
differences in internalization of BSA-NP complexes as a function of NP charge, and
identify the mechanism as either clathrin- or caveolin-dependent. We anticipate that
differences in the rate or internalization mechanism are due to the receptor used by






























Figure 43: Transport studies of BSA-NP complexes and BSA-AF647 in BS-C-1
cells as a function of incubation time at 37 ◦C. The LAMP1 protein was used as an
endpoint for transport. Merged images show colocalization after an 18 hour incuba-
tion. (A) BSA-NP complexes (green) in cells labeled with LAMP1-Cy5 (red). (B)
BSA-AF647 (red) in cells expressing LAMP1-EYFP (green). (C) Colocalization of







Figure 44: Individual images from transport studies of BSA-NP and BSA-AF647 to
LAMP1 positive vesicles used to construct merged images shown in Figure 43.
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While we examined cellular transport using accumulation at single time points,
the dynamics of transport may also differ as a function of NP charge as a result of
the complexes formed with anionic and cationic NPs using different cellular receptors.
Single particle tracking experiments have been initiated, but no differences were ob-
served between transport kinetics of vesicles containing BSA or BSA-NP complexes.
Transport experiments are challenging as vesicles transport multiple types of cargo
simultaneously, including many intracellular proteins. It is difficult to deduce the
effect the type of molecule contained within the vesicle has on the overall transport
dynamics. Future experiments will need to characterize vesicle transport in vitro to
first understand an isolated system, followed by intracellular studies of the dynam-
ics of transporting proteins versus protein-NP complexes. This will require the use
of multi-color particle tracking, perhaps in conjunction with sub-diffraction limited
imaging.
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The following appendix describes methods in expanded detail and includes suggestions
for experimental design and optimization.
7.1 Cell Experiments
Cell health, the pH of the cell culture medium, and passage number all influence the
outcome of cellular binding and internalization experiments. All experiments should
be repeated with cells from multiple passage numbers to control for heterogeneity
in phenotype often observed in cultured cells. For cellular binding, medium with a
pH of 7.2 for MEM and 7.4 for MEM supplemented with 10% (v/v) FBS was used.
Difficulties repeating cellular binding experiments can often be traced to a change in
the pH of the medium over time.
Cellular binding experiments were always performed in culture dishes or well plates
incubated on a bed of ice covered with aluminum foil. Incubation in a 4 ◦C fridge
is another method for cold binding studies. However, the cells and the medium
equilibrate much slower using this method and the temperature is maintained more
homogeneously on ice.
7.2 Microscopy
7.2.1 Wide Field Fluorescence
Wide field fluorescence microscopy has the advantage of faster acquisition time over
confocal microscopy, but multiple images cannot be recorded simultaneously. When
acquiring images from multiple fluorophores in a single spatial region, the focus (or
z position) of the microscope should be kept constant between images, ensuring that
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overlaid images accurately reflect the spatial location of the fluorophores. Time course
recordings are also possible with the wide field microscope, however, there is a slight
drift in the z position over time (x and y positions are relatively constant). Re-
centering the illumination from the xenon lamp often improves image quality. The
aperture iris condenser can also be aligned, however this will only improve the bright
field image quality and will have no effect on the final image acquired on the CCD
camera. Changing the xenon bulb is also required after 1000 - 2000 hours of use, and
care should be taken to ensure that the new bulb is aligned properly (see Olympus
Manual).
Calibration of the microscope (i.e. determining the distance in nm per pixel)
should be done regularly. This is achieved by acquiring an image of a calibration
slide at the same magnification used in experiments. The image should contain a
calibration ruler with 10 lines spaced 10 nm apart, and the pixels in the image are then
counted as a function of distance using ImageJ. For all images used in this thesis, the
calibration was calculated for multiple widths along the calibration ruler and averaged
to acquire a final value. Experimental calibration values can be corroborated with
the calculated value using the pixel size of the CCD and objective magnification.
7.2.2 Confocal Fluorescence
For static imaging, the confocal imaging system should be turned on 30 minutes to
1 hour prior to use. For live cell imaging, allowing the system to warm up over
several hours is required to eliminate axial drift and equilibrate laser emission. The
emission pinhole should be set to a size of 1 airy unit for best resolution. The pinhole
can opened beyond this size to simulate ‘wide field’ imaging, but doing so allows
more background and out-of-focus light to reach the detector without increasing the
excitation volume.
Images used for comparison, including control samples, must be acquired with
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the same dwell time, PMT voltage, pinhole size, and laser power. It is important to
ensure that the PMT detectors are not oversaturated during imaging using the hi-lo
look-up tables in the FluoView software. The calibration that is exported with the
images is accurate and has been checked with external calibration.
7.2.3 Dark Field
Dark field microscopy was used to image the cellular binding of gold NPs and is
shown in Figure 45. NPs down to ∼30 nm in diameter can be visualized with dark
field microscopy. Samples were prepared for dark field measurements by sealing the
cells adhered to a circular cover slip between a clean, rectangular cover slip (Figure
45A). A small amount of glycerol is placed between the cover slips, and the edges are
sealed with either nail polish or epoxy to prevent from drying. Samples prepared in
this manner can be kept for up to one week at room temperature.
The dark field microscopy setup in our lab was assembled using an upright Olym-
pus microscope. A dark field condenser with a numerical aperture (N.A.) greater
than that of the objective is used to focus a narrow beam of light, or a hollow il-
lumination cone, onto the sample. An iris objective with a variable N.A. is used to
collect scattered, but not transmitted, photons (Figure 45B). While the objective and
condenser are shown at a distance above and below the sample to demonstrate the
optical path, both are oil objectives and require direct contact with the cover slips.
A Nikon D200 DSLR is used to acquire images. The camera is attached to
the top port of the microscope and is directly connected to the computer via USB.
Open source micro-manager software (www.micro-manager.org, version 1.4) is used
for viewing images. The NK Remote software (version 2.7) interfaces micro-manager
with the Nikon D200. While we have purchased a one year license, this software can































Figure 45: Dark field microscopy instrumentation. (A) Schematic of sample prepa-




General experimental challenges for fluorescence and absorption spectroscopy include
interference in the UV region by strong absorbers (e.g. chloride, polystyrene), inner
filter effects at high concentrations, and scattering. Contributions to the inner filter
effect should be characterized for each experiment, especially for strongly absorbing
or strongly scattering molecules and particles.
For circular dichroism spectroscopy, the concentration of the sample is one of the
most important parameters. While higher sample concentration can increase sample
absorption, an increase in absorption also results in fewer photons reaching the PMTs.
This in turn leads to higher PMT voltage (and often a longer integration time) and
a decrease in the signal-to-noise ratio. Optimization of concentration and buffer are
essential for accurate and reproducible spectra. There is also considerable baseline
drift over time. The baseline should be checked frequently by acquiring another
spectrum of buffer alone with the baseline correction applied. A spectrum that is flat
within ±1 millidegree (instrument noise range) is acceptable. Baseline drift should
only be subtracted if first verified by measuring the baseline and sample at similar
times, using a region of the sample spectrum where the signal should be zero. If
magnitude of the baseline drift from the buffer and the sample is the same, then a
change in baseline can be attributed to instrument, rather than sample, fluctuations.
Spectra are generally reported in units of molar ellipticity or mean residue ellipticity.
If a spectrum is smoothed, a difference spectrum should be calculated for the raw
and smoothed spectra. If there are no features greater than the instrument noise (±1
millidegree), then the spectrum has not been oversmoothed.
7.4 Isothermal Titration Calorimetry
A general isothermal titration calorimetry (ITC) experiment consists of ligand loaded
into the titration syringe and substrate loaded into the cell at a concentration of 10:1
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ligand to substrate, assuming one-to-one binding. Accurate ligand concentration is
required to obtain reliable thermodynamic parameters. For weak binding, the con-
centrations should be at least as large as the Kd. The reference cell should always be
filled with water, regardless of the buffer loaded into the sample cell, and the refer-
ence and sample cells must be filled accurately to the same volume. Either distilled
or deionized water can be used for the reference cell and for cleaning. Nanopure
water is not required and should not be used for washing as large volumes of water
are needed to clean the instrument thoroughly. The ligand and substrate buffer must
be matched within 0.1 pH units, or pH effects will be visible in the titration curves
and are difficult to subtract out. Water is generally never used as the solvent in an
ITC experiment for this reason. A control titration of ligand into buffer alone must
always be completed and subtracted from the experiment titration. Under optimal
conditions, the integrated peaks will be 4-5 times larger for the experiment compared
with the control, but this is not always possible for weak binding systems.
Optimal settings range from 250-350 rpm for stirring, 16-25 injections, and 1-4 µL
injections. Both the syringe and cell should be washed with water followed by buffer
prior to loading each with sample. The titration syringe must be completely dry
before filling and void of bubbles after filling. The first injection should be discarded
during data analysis as some of the volume will diffuse out of the injection syringe
prior to the first injection.
A clean instrument, proper controls, and unbiased fitting of the data are critical for
acquiring accurate thermodynamic parameters. Optimization of ligand and substrate
concentration, buffer, equilibration time, and temperature will be required for every
experiment. Final thermodynamic values are highly dependent upon buffer, chemical
composition, and temperature. Reproducibility is key.
An instrument quality control check, which should be done on a weekly basis if the
instrument is in frequent use, is to run a water-water titration. With water in both the
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titration syringe and in the cell, twenty 2.5 µL titrations should give consistent peaks
of 5 µJ each. Deviations in the water-water run, a noisy baseline, and inconsistent
peaks are all indicators that the instrument is not clean. A solution of 20% (v/v)
contrad solution can be used for rigorous cleaning. However, the contrad itself is very
difficult to remove completely and should be used sparingly. Yearly maintenance
should include soaking the cell with contrad at 60 ◦C (avoiding inhalation of any
contrad fumes), greasing the o-rings in the buret handle, and running instrument
gain calibration. There are many tutorials available on TA Instrument’s website for
further details and visual explanations.
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